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ABSTRACT
The reduction of the polar azo compound amaranth by hepatic 
microsomal NADPH-dependent electron transport components was 
investigated under anaerobic conditions. This activity was increased 
by riboflavin, FMN and FAD. Azoreductase activity in the absence or 
presence of flavins was increased or decreased, respectively, by 
type I or type II cytochrome P-450 substrates and ligands, and 
inhibited by carbon monoxide. Pretreatment of rats with cobaltous 
chloride, carbon tetrachloride or allylisopropylacetamide decreased 
azoreductase activity. Phenobarbitone or 3-methylcholanthrene 
increased the specific activity of the microsomal azoreductase in 
the absence of flavin, but had no effect on the flavin supplemented 
activity. Alkylation of the microsomal fraction with 2-bromo-4’-nitro- 
acetophenone or proteolytic digestion by trypsin decreased both 
azoreductase activities. Azoreductase activity was reconstituted 
from purified NADPH-cytochrome c (P-450) reductase, cytochrome P-450 
and dilauroylphosphatidylcholine liposomes. Possible mechanisms of 
interaction between the components of the NADPH-dependent electron 
transfer system and flavins and amaranth are discussed. It is 
proposed that cytochrome P-450 is the terminal electron donor 
during the microsomal reduction of amaranth and flavins.
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Chapter 1 
GENERAL INTRODUCTION
1.1. Microsomal electron transport components
The mammalian hepatic microsomal fraction catalyses the oxidative 
transformation of a wide range of endogenous substrates (Hamberg et al., 
1974; Brenner, 1977) and non-nutritive foreign compounds (Orrenius, and 
Emster, 1974; Ullrich and Kremers, 1977). The system requires 
NADPH and molecular oxygen for activity (Mueller and Miller, 1953; 
Axelrod, 1955; Brodie et al., 1955) and performs the following 
general reaction, where RH is the substrate and ROM the product:
RH + NADPH (H) + C>2  ► ROH + NADP+ + I^O
It has been established that this hydroxylation system consists of 
two protein components; a haemoprotein, cytochrome P-450, and a 
flavoprotein NADPH-cytochrome c (P-450) reductase (Lu and West, 1978). 
Cytochrome P-450 provides the active site for this reaction, while 
NADPH-cytochrome c (P-450) reductase transports electrons from NADPH 
to this haemoprotein. NADPH-cytochrome c (P-450) reductase may 
itself catalyse the oxidative degradation of haem (Masters and 
Schacter, 1971) or transfer electrons to a distinct haem oxygenase 
(Maines et al., 1977). This flavoprotein has also been implicated in 
the metabolism and toxicity of carbon tetrachloride (Slater and 
Sawyer, 1971). In addition, the microsomal membrane contains a 
NADPH-dependent flavoprotein oxidase responsible for the N- 
and S-oxidation of a number of substrates (Ziegler and Poulsen, 1978), 
and a NADH-dependent electron transfer chain composed of NADH- 
cytochrome b^ reductase, cytochrome b^ and a cyanide sensitive
factor responsible for the desaturation of fatty acids (Oshino 
et al., 1966; Joshi et al., 1977).
The hepatic microsomal fraction may also catalyse the NADPH- 
dependent reductive transformation of azo compounds (Walker, 197Q), 
nitro compounds (Gillette, 1971) and tertiary amine N-oxides (Iwasaki et al. 
1977; Kato et al., 1978) under anaerobic conditions. Both NADPH- 
cytochrome £ (P-450) reductase and cytochrome P-450 are required for 
these reactions, with cytochrome P-450 functioning as the terminal 
electron donor. However, the reduction of azo compounds may also 
involve a direct interaction between this NADPH-dependent flavo­
protein and the azo acceptor (Hernandez et al., 1967a, b).
The factors involved in electron transport from NADPH to 
cytochrome P-450 and the interaction of this haemoprotein with the 
flavoprotein reductase and substrate are discussed in subsequent 
sections, as are factors involved in the hepatic microsomal reduction 
of aromatic azo compounds.
1.2. Properties of hepatic microsomal cytochrome P-450
Cytochrome P-450 provides both the substrate and oxygen binding 
sites of the monooxygenase system, and many compounds known to be 
substrates for this enzyme complex combine with the oxidised 
haanoprotein. Remmer et a£. (1966) showed two distinct types of 
interaction, characterised by ’’type I” and ’’type II” difference specira.
The type I difference spectrum was typified by compounds such as 
aminopyrine, hexobarbitone and chlorpromazine, and possessed a 
peak at about 385 nm and a trough at about 420 nm. The majority 
of substrates for the microsomal monooxygenase produced a 
spectrum of this kind, which appears to be the optical expression 
of the substrate-cytochrome P-450 complex (Remmer et al., 1966; Schenkman 
et al., 1967). Compounds possessing a basic nitrogen, such as aniline, 
pyridine and nicotine gave a type II difference spectrum, characterised 
by a peak at about 430 nm and a trough around 395 nm. This spectral 
change was thought to represent a complex between haem-iron of cytochrome 
P-450 and the basic nitrogen of the amine (Schenkman et al_., 1967).
In the absence of endogenous substrates, the membrane bound form of 
cytochrome ‘P-450 exists as an equal mixture of low and high spin forms, 
while the solubilised, purified haemoprotein is mainly in the low spin 
state (Gibson et al., 1979). This high/low spin equilibrium responds to 
changes in temperature with the generation of an apparent type I binding 
spectrum, without the addition of substrate (Cinti et al., 1979).
Once cytochrome P-450 lias bound a type I substrate, the haem-iron 
is mainly in the high spin state, with a concomitant increase in redox 
potential (Gunsalus et al., 1974; Sligar et al., 1979). This 
facilitates electron transport to the cytochrome P-450/substrate 
complex from NADPH-cytochrome £ (P-450) reductase (Gigon et al., 1969). 
Conversely, in the presence of type II substrate the low spin state 
predominates (Rein et al., 1977), and the rate of cytochrome P-450 
reduction is decreased (Gigon et al., 1969).
In the reduced state, cytochrome P-450 reacts with carbon 
monoxide to yield a difference spectrum with a maximum at 450 nm 
(Klingenberg, 1958; Qmura and Sato, 1964a, b). This unique 
property is used to quantitate cytochrome P-450. In addition, 
carbon monoxide competes with oxygen for a common binding site at 
the iron-centre of cytochrome P-450 and inhibits both the oxidative 
(Estabrook et al., 1970) and reductive (Gillette, 1971) activities 
of this haemoprotein.
Cytochrome P-450 has been purified to apparent homogeneity by 
detergent solubilisation of the microsomal fraction, followed by 
column chromatography on DEAE-cellulose (Imai and Sato, 1974;
West et al., 1979). The purified haemoprotein had a molecular 
weight of approximately 50,000 daltons, as estimated by SDS-polyacryl­
amide gel electrophoresis. However, studies of this nature 
indicated an extensive heterogeneity in the types of cytochrome P-450 
present in the microsomal fraction from control rats (Warner et_ a£.,
1978). Further, the specific content of some of these forms of 
haemoprotein was increased by the pretreatment of animals with a 
range of compounds typified by phenobarbitone or 3-methylcholanthrene 
(Welton and Aust, 1974). Peptide mapping of these multiple forms of 
cytochrome P-450 indicated differences in the primary structure of the 
haemoprotein predominating in the hepatic microsomal fraction from 
control, phenobarbitone- or 3-methylcholanthrene- pretreated animals 
(Guengerich, 1978; Johnson et al., 1979). This was reflected by 
differences in molecular weight; control- and phenobarbitone-type 
cytochrome P-450 had an apparent molecular weight of 48,000 - 50,(XX)
daltons while the 3-methylcholanthrene form gave a value of 54,000 
daltons, (Guengerich, 1977, 1978). In addition, the difference 
spectrum of the carbon monoxide complex of these haemoproteins was 
different, with the phenobarbitone type possessing an absorption 
maximum at 450 nm, while 3-methylcholanthrene induced a haemoprotein 
with an absorption maximum at 448 nm (Kuntzman, 1969; Ullrich and 
Kremers, 1977). These two major forms of this haemoprotein have come 
to be termed cytochrome P-450 and cytochrome P-448, respectively.
1.3, Properties of NADPH-cytochrome c (P-450) reductase
Initial studies indicated that NADPH-cytochrome c (P-450) 
reductase was a flavoprotein, capable of transporting electrons from 
NADPH to cytochrome c (Horecker, 1950; Phillips and Langdon, 1962; 
Williams and Kamin, 1962). The physiological role of this reductase 
was unclear, since cytochrome c is a constituent of mitochondria, 
but this activity was located within the microsomal fraction.
Subsequent studies demonstrated that this flavoprotein was involved 
in the monooxygenase activities of the microsomal fraction (Ernster 
and Orrenius, 1965; Masters et al., 1971; Prough and Burk, 1975).
Purified hepatic microsomal NADPH-cytochrome P-450 reductase 
contains both FMN and FAD as prosthetic groups, in the ratio of 1 mol
of each flavin per mol of flavoprotein (Iyangi and Mason, 1973). A
common enzyme was found in the microsomal fraction from several
tissues, with kidney (Fan and Masters, 1974), lung (Philpot et al., 1975)
and spleen (Iyanagi, 1974) reductases resembling the hepatic 
enzyme. In addition, the flavoprotein isolated from rabbit hepatic 
tissue closely resembled its counterpart from the rat (French 
and Coon, 1979).
Recent purification of this flavoprotein by detergent solubilisation 
and affinity chromatography have resulted in the isolation of homogenous,
L .
highly active preparations of NADPH-cytochrome £ (P-450) reductase 
(Dignam and Strobel, 1975, 1977; Yasukochi and Masters, 1976).
The purified enzyme had a molecular weight of 78,000 - 80,000 daltons as 
determined by polyacrylamide gel electrophoresis and was active in 
reconstituting monooxygenase activity when incubated with purified 
cytochrome P-450 and phospholipid (vide infra). In contrast, the 
flavoprotein purified after protease solubilisation was unable to 
reconstitute monooxygenase activity (Aust et al_., 1972; Ichihara et al.,
1972). This digestion apparently removed part of the polypeptide chain 
yielding a flavoprotein of estimated molecular weight 71,000 daltons 
(Welton et al., 1973 ). This lost peptide fragment is needed for the 
transfer of electrons to cytochrome P-450, and binding of the flavo­
protein to the microsomal membrane (Pokrovsky et al_., 1977; Gum and Strobel,
1979). However, both protease- and detergent-solubilised preparations 
possessed similar activities towards non-physiological electron 
acceptors such as cytochrome c and potassium ferricyanide (Masters et al., 
1965; Vermillion and Coon, 1976).
1.4. The mechanism'of electron transfer reactions catalysed by 
NADPH-cytochrome c (P-450) reductase
In principle, NADPH-cytochrome c (P-450) reductase can exist in
8nine redox states, representing the different degrees of reduction 
of the two flavin prosthetic groups (Iyangi and Mason, 1973). In order 
to function as the input of electrons into the cytochrome P-450 
catalytic cycle, the flavoprotein must mediate the sequential one 
electron reduction of the haemoprotein using the two electron 
reductant, NADPH(H). The initial interaction between the reduced 
pyridine nucleotide and the reductase occurs via a low potential 
"acceptor flavin", while the supply of reducing equivalents to 
cytochrome P-450 is maintained by a high potential "donor flavin"
(Iyangi et al., 1974). Possible schemes permitting this internal 
transfer of electrons between the two flavins: are presented in Fig. 1.1.
A similar proposal was made by Siegel et al.(1972) to account for 
the intramolecular transfer of reducing equivalents to the microbial 
NADPH-sulphite reductase. This enzyme, like NADPH-cytochrome £
(P-450) reductase, contains both FMN and FAD prosthetic groups, and 
a similar "step-down" mechanism is required for the transfer of 
electrons from NADPH(H) to one electron acceptors.
The selective removal of FMN from the purified flavoprotein by 
dialysis against high ionic strength potassium bromide lias permitted 
the identification of the high- and low-potential flavins of NADPH- 
cytochrome c (P-450) reductase (Vermillion and Coon, 1976, 1978; 
Alexander, 1979). Such preparations showed a greatly decreased 
activity towards cytochrome c and cytochrome P-450 as electron acceptors, 
wThile the reduction of potassium ferricyanide remained unaffected. 
Reconstitution of FMN onto the apoenzyme gave a flavoprotein 
preparation with spectral and catalytic properties highly similar
Possible mechanisms of internal disproportionation of 
reducing equivalents by NADPH-cytochrome c (P-450) reductase
(i) NADPH + II+ + F1 -------- ► NADP+ + F ^
F1H2 + F2  “ F1 + F2H2
F2H2 + (P-450 - RH)3*  ► F2H‘ + (P-450 - RH)2*+ H +
(P-450 - RH)2++ 02  > (P-450 - RH - 02)2*
F2H‘+ (P-450 - RH - 02)2+  >* F + (P-450)3 + ROH + OH-
(ii) F ^  + F2  ► y H - + FJH
F-H- + (P-450 - RH)3*  ► F2 + (P-450 - RH)2*± H+
(P-450 - RH)2* + 02  ► (P-450 - RH - 0,).2*
F1H2 + (P-450 - RH - 02)2*  ► F.H' + (P-4SO)3+ ROH + 0H~
NADPH + H + F1H,+ F2  ► NADP + F.FL + F2H'
(iii) F2 + NADPH + H+  ► F2H2 + NADP +
F2»2 + F1  ** F2H" + F1H‘  > F2 + F1H2
F1H2 + CP-450 - RH)3*  «• F1H-+ (P-450 - RH)2*+ H*
F2 + FjH' + NADPH + H* -------- ► F2H2 + F,H' + NADP+
F2H2 + F1H' + (P-450 - RH)2*+02 ---- ► F2H* + FiH‘+ (P-450)3*+R0H + 0H
or
F2+ F,H2 + (P-450)3}- ROH + OH-
F^ and F^ are the two flavoprotein prosthetic groups.
RH and ROH represent the product and substrate of the monooxygenase, 
respectively.
(After Iyanagi et al., 1974)
to the holoenzyme. These observations suggest that FAD is the 
low potential flavin that interacts with NADPH, and which may also 
donate electrons to potassium ferricyanide. However, the reduction 
of other electron acceptors such as cytochrome c and cytochrome P-450 
requires the presence of FMN, which acts as the high potential donor 
flavin.
1.5. The interaction between NADPH-cytochrome c_ (P-450) reductase 
and cytochrome P-450
Early studies on the hepatic microsomal monooxygenase system 
demonstrated that a third component, in addition to NADPH-cytochrome c 
(P-450) reductase and cytochrome P-450, was essential to reconstitute 
the metabolism of fatty acids (Lu and Coon, 1968). This heat stable, 
lipid factor was later identified as phosphatidylcholine (Strobel et al. 
1970). Hewever, this phospholipid requirement may be replaced by 
several nonionic detergents at appropriate concentrations (Lu and 
West, 1978). The exact mode of action of these materials is unknown, 
but a non-aqueous environment seems to be needed for the efficient 
transfer of electrons from the flavoprotein reductase to cytochrome 
P-450 (Strobel et al., 1970; Coon et al., 1976).
It has been proposed that the flavoprotein protrudes above the 
surface of the microsomal membrane, with cytochrome P-450 embedded 
within a lipid environment (Estabrook et al., 1971). As the ratio 
of cytochrome P-450 to NADPH-cytochrome £ (P-450) reductase is about 
20 : 1 , one reductase molecule must interact with a number of 
haemoprotein molecules for efficient catalysis. A lipid environment
would facilitate this transfer by allowing translational movement 
within the membrane.
Electron transfer from NADPH-cytochrome £ (P-450) reductase to 
cytochrome P-450 is usually monitored by following the anaerobic 
formation of the carbon monoxide complex of ferrous cytochrome P-450 
(Gigon et al., 1969; Matsubara et al., 1976). Under these conditions, 
haemoprotein reduction corresponds to two independent first order 
reactions- one fast, one slow. The fast phase of cytochrome P-450 
reduction may represent electron transfer to haemoprotein molecules 
close to the central flavoprotein reductase, without the need for 
translational motion through the membrane. In contrast, the slow 
phase may represent the reduction of isolated haemoprotein molecules 
not directly associated with the flavoprotein (Peterson et al., 1976).
According to this non-rigid model, the incorporation of additional 
cytochrome P-450 into the microsomal membrane should increase activities 
associated with this haemoprotein. Thus, the addition of cytochrome 
P-448 to the control microsomal fraction enhanced the activity of the 
microsomal benzo(a)pyrene hydroxylase (Yang, 1977), and increased the 
rate of cytochrome P-450 reduction in a reconstituted system (Taniguchi 
et al., 1979). Also, the binding of detergent purified NADPH-cytochrome 
£ (P-450) reductase to the microsomal membrane increased benzo(a)- 
pyrene hydroxylation, benzphetamine demethylation and ethoxycoumarin 
dealkylation (Pokrovsky et al., 1977; Yang et al., 1978). The rate 
of formation of the ferrocytochrome P-450 carbon monoxide complex was also 
enhanced.
1.6. The reductive metabolism of aromatic azo compounds
The biological reduction of azo compounds is a reaction of 
historical significance in the field of drug metabolism. Studies on 
prontosil by Trefouel et al. (1935) demonstrated that the therapeutic 
properties of this drug against streptococcal infections was due to 
the reduction of the nitrogen double bond with the formation of 
sulphanilamide. Subsequent studies indicated that this activity 
was located within the microsomal fraction, and was a component of the 
NADPH-dependent electron transport system (Gillette, 1971; Walker, 1971; 
Khera and Munro, 1979). However, the identity of the enzyme 
responsible for this activity is equivocal, as both NADPH-cytochrome c 
(P-450) reductase and cytochrome P-450 have been reported as possessing 
azoreductase activity.
The suggested role of these electron transfer components during the 
reductive cleavage of aromatic azo dyes will be discussed in subsequent 
sections. The structure of those azo compounds mentioned in this 
dissertation are given in the Appendix.
1.7. Mechanisms of azo dye reduction
The reductive cleavage of azo compounds into their component primary 
amines proceeds more readily in the absence of oxygen. Fouts et al. (1957) 
demonstrated inhibition of the reduction of azobenzene, prontosil and 
butter yellow when aerobic azoreductase activity of rabbit liver
homogenates was compared with that observed under an atmosphere of 
nitrogen. The degree of inhibition m s  dependent on the azo substrate, 
with azobenzene showing the greatest oxygen inhibition (fifty per cent) 
and buffer yellow the least (ten per cent). A similar insensitivity 
of butter yellow reduction lias been danonstrated by other workers 
(Mueller and Miller, 1950; Autrup and Warwick, 1975).
The early models of the mechanism of azoreduction proposed two 
successive two electron transfers to the substrate, with the 
formation of a hydrazo intermediate (Ross and Warwick, 1955; Fouts 
et al., 1957).
Ar— N = N— Ar'
Ar— N - N — Ar1
I II i
H H
Evidence for these two steps was obtained by Bray et al_. (1951) who 
detected hydrazobenzene in the urine of rabbits given azobenzene.
Subsequent to these studies, Hernandez et al. (1967a) noted that 
oxygen or air inhibited sulphanilamide production when neoprontosil was 
incubated with liver microsomes or soni-purified. NADPH-cytochrome c 
reductase. To explain this observation, these authors suggested that 
the hydrazo intermediate was oxidised with the regeneration of 
neoprontosil and water.
2H (
 ► Ar —  N - N—  Ar hydra zo
I I intermediate
H H
2H
^  ArNH2 + Ar NH2
These observations complemented earlier studies that aerobic 
incubation of methyl orange with hepatic tissue preparations respired 
oxygen without any net decrease in azo dye concentration (Manchon and 
Lowy, 1965). However, recent work has questioned the sensitivity 
of this hydrazo intermediate to aerobic autooxidation (Mason et al., 1978). 
Aerobic microsomal incubations reduced the polar azo dye sulphonazo III 
at the same rate as the aerobic, non-enzymic reduction mediated by 
NADPH in the absence of microsomes. However, those incubations 
containing NADPH alone did not consume oxygen. Thus, hydride transfer 
from NADPH to the azo dye was postulated to yield the two electron 
reduced hydroazo form, which did not react with oxygen to any appreciable 
extent (Mason et al., 1978). Therefore, these studies suggest that the 
oxygen sensitivity of the hepatic azoreductase is unlikely to result 
from the reoxidation of this half-reduced intermediate.
Studies utilising electron spin resonance spectroscopy (ESR) 
have detected a radical intermediate formed during the microsomal reduction 
of the polar azo dyes sulphonazo III and amaranth (Mason and Holtzman,
1976; Peterson and Mason, 1977; Masonet al., 1977, 1978).
The signal from this radical was compatible with the formation of 
a one electron reduced azo anion during the reduction of these 
compounds (Peterson and Mason, 1977).
• Ar— N =  N —  Ar' + e ------Ar— N — N — Arf azo anion
radical
This intermediate reacted, with oxygen with the simultaneous 
disappearance of radical signal and the production of superoxide anion 
radical (Mason et al., 1978). Under these aerobic conditions, the 
concentration of the azo compound remained unchanged in NADPH-supplemented 
microsomal incubations while oxygen consumption increased,as did 
the rate of NADPH oxidation. These findings were not inconsistent 
with the findings of Manchon and Lowy (1965) (vide supra).
In the absence of oxygen, this ESR signal was unaffected by 
carbon monoxide, even though the rate of dye reduction was decreased 
(Mason et al., 1977, 1978). This led to the proposal that NADPH-
cytochrome c (P-450) reductase was responsible for the initial one 
electron reduction of the azo compound, while reduction of the azo 
radical was mediated by cytochrome P-450 (Mason et al., 1977). However, 
there is no evidence to indicate whether the free radical anion is an 
obligate intermediate during microsomal azoreduction. Azo anion 
radicals can disproportionate in aqueous solution to form hydrazo 
compounds (Thomas and Boto, 1975) which may explain the identification 
of this intermediate in some studies (Bray et al., 1951; Ross and 
Warwick, 1955).
In order to overcome the oxygen sensitivity of this reaction, 
inert gases such as nitrogen or argon have been used in an attempt to 
displace dissolved oxygen from the assay medium (Hernandez et al., 1967a; 
Fujita and Peisach, 1978a). Nonetheless such procedures still result 
in an appreciable lag period prior to the initiation of dye reduction, 
presumably due to the presence of residual oxygen (Mallett eit cd., 1977).
Many of the methods reported for the estimation of azoreductase 
activity have relied upon fixed-time assays (Fouts et al., 1957;
Hernandez et al., 1967a; Ketterer et al., 1970; Autrup and Warwick 
1975) and made no allowance for this initial lag period. Therefore, 
these results may contain varying degrees of error due to an underestimation 
of the azoreductase activity present.
1»8>. Microsomal enzymes involved in the reduction of azo compounds
Mueller and Miller (1948; 1949; 1950) demonstrated that butter 
yellow was reductively cleaved by NADPH-dependent enzymes located in 
the hepatic microsomal fraction from the rat. The enzyme responsible 
for this reaction was inactivated when the post-mitochondrial 
supernatant was dialysed against distilled water saturated with 
carbon dioxide (Mueller and Miller, 1950). Activity was restored by 
the addition of FAD, which also stimulated butter yellow reduction 
when added to undialysed preparations. This observation correlated 
with the finding that rats fed high riboflavin containing diets were less 
prone to the tumour-inducing effects of butter yellow (Miller et al., 1948) 
and indicated that reduction decreased the toxic properties of this 
compound (Kadlubar et al., 1976).
Fouts et al. (1957) investigated the reduction of prontosil by 
rabbit liver homogenates but in contrast concluded that the majority 
of the azoreductase activity was present in the post-microsomal 
supernatant. This oxygen-sensitive reaction had a specific
requirement for NADPH as cofactor, with NADH being totally inactive.
In common with the rat hepatic azoreductase, mild acid treatment 
resulted in a fifty percent decrease in product formation. Full 
activity was restored upon supplementation with riboflavin, FMN 
o^ FAD with all three flavins possessing similar activities.
These authors proposed that the flavins acted in two ways;
(i) as prosthetic groups which became dissociated upon exposure 
to mild acid leaving an inactive apoenzyme and (ii) as soluble 
hydrogen transporting entities similar to a cofactor (Fouts et al., 1957). 
The accelerating influence of flavins would be due to this latter property.
Subsequent to this work, Hernandez et al. (1967a) demonstrated 
that the partial purification of hepatic microsomal NADPH-cytochrome c 
(P-450) reductase resulted in the co-purification of anaerobic 
neoprontosil reductase activity. The purified preparation appeared 
homogeneous after gel electrophoresis, and when unstained gels were ' 
leached with buffer and tested for enzyme activity, NADPH-cytochrome c 
(P-450) reductase, neotetrazolium reductase and azoreductase 
activities were located within the same area of the gel. This 
suggested that a single protein may be responsible for the reduction 
of these electron acceptors. Nonetheless, a second azoreductase 
pathway was apparently destroyed during the initial digestion with 
steapsin, as the solubilised microsomal protein showed a twenty 
per cent increase in the NADPH-dependent reduction of cytochrome c, 
while neoprontosil reduction was decreased by one half. Subsequent 
work' • demonstrated that this second pathway was dependent on
cytochrome P-450. Normal microsomes were characterised as containing 
a carbon monoxide sensitive, solubilisation sensitive activity 
mediated by cytochrome P-450, and a carbon monoxide insensitive, 
solubilisation insensitive pathway mediated by the flavoprotein, 
NADPH-cytochrome c (P-450) reductase (Hernandez et al., 1967a, b).
During studies on the kinetics of neoprontosil reduction,
Sasame (1969) examined the disappearance of various concentrations 
of this azo compound under nitrogen or carbon monoxide. Low substrate 
concentrations were almost totally inhibited by carbon monoxide, 
while increasing the concentration of azo substrate resulted in only 
partial inhibition. A Dixon plot of these results indicated non­
competitive inhibition, while Lineweaver-Burk plots gave curves for 
both the total and carbon monoxide sensitive azoreductase activities. 
Although such data obtained with the microsomal fraction cannot be 
interpreted unequivocally, the presence of a multienzyme system has 
been suggested to explain these results (Gillette, 1971).
Treatment with phenobarbitone has been shown to induce both 
components of the microsomal NADPH-dependent electron transfer 
chain (Lu and West, 1978), and azoreductase activity (Mazel and 
Hernandez, 1967; Hernandez et al., 1967b). In intact microsomes, 
this elevation of azoreductase activity was closely associated with the 
induction of microsomal cytochrome P-450 content, and the 
pheno barb i tone - indue ed activity was more sensitive to carbon monoxide 
inhibition than the activity present in controi microsomes (Hernandez et al.
1967b). The carbon monoxide insensitive route of neoprontosil 
reduction was unchanged after this induction, in spite of an 
increase in the specific activity of NADPH-cytochrome c (P-450) 
reductase. However, steapsin solubilisation of phenobarbitone- 
induced microsomes resulted in an increased rate of dye reduction 
by a pathway that was insensitive to carbon monoxide. This suggested 
that disruption of the microsomal membrane was required before the 
induced NADPH-cytochrome £ (P-450) reductase could participate in 
neoprontosil reduction, suggesting that the flavoprotein was tightly 
coupled to cytochrome P-450 in the intact microsomal membrane.
The pretreatment of rats with 3-methylcholanthrene induced hepatic 
microsomal azoreductase activity and increased the sensitivity of this 
activity to carbon monoxide inhibition (Hernandez et al., 1967b). The 
flavoprotein mediated, carbon monoxide insensitive pathway was 
.unchanged in activity. These results correlate with the reported 
effects of 3-methylcholanthrene pretreatment, which induces a 
modified species of drug metabolising haemoprotein, namely cytochrome 
P-448 (Ullrich and Kremers, 1977; Lu and West, 1978), with no change 
in the activity of NADPH-cytochrome c (P-450) reductase (Hernandez 
et al., 1967b). In addition, 3-methylcholanthrene was reported to 
induce an additional route of neoprontosil reduction distinct from 
c^ rtochrome P^450 or NADPH-cytochrome c (P-450) reductase. This novel 
pathway was insensitive to carbon monoxide, yet was destroyed upon 
treatment with steapsin (Hernandez et ad., 1967b).
Animals maintained on a riboflavin deficient diet showed 
decreased hepatic flavin levels, along with decreased activity of 
NADPH-cytochrome c (P-450) reductase, while cytochrome P-450 
content remained unchanged (Shargel and Mazel, 1973). However, the 
activities of the total and the carbon monoxide insensitive azoreductases 
were*decreased, while the sensitivity of neoprontosil reduction to 
carbon monoxide inhibition was increased (Shargel and Mazel, 1968; 1973). 
These changes followed the decrease in activity of NADPH-cytochrome c 
(P-450) reductase. However, phenobarbitone induction increased the 
cytochrome P-450 content and NADPH-cytochrome c (P-450) reductase and 
azoreductase activities of the microsomal fraction. In contrast, 
pretreatment of animals with 3-methylcholanthrene gave only a small 
increase in azoreductase activity, in spite of a large increase in 
cytochrome P-448 content; additional dietary flavin was required before 
a more extensive increase in the rate of neoprontosil reduction was 
observed after induction with this carcinogen (Shargel and Mazel, 1968;.
1973). These authors suggested that part of the mechanism of the 
induction of azoreductase activity by 3-methylcholanthrene was due to 
a change in the structure or composition of NADPH-cytochrome c (P-450) 
reductase (Shargel and Mazel, 1973).
The induction of azoreductase activity with phenobarbitone and 
3-methylcholanthrene has also been reported by other workers in this 
field (Autrup and Warwick, 1975; Autrup et al., 1975; Fujita and 
Peisach, 1978a} Mallett et al., 1978). However, the type of azo 
substrate may determine which microsomal enzymes are involved in dye
reduction. Thus Autrup and Warwick (1975) noted that reduction of 
butter yellow (lipophilic) k was induced in the post-mitochondrial 
supernatant fraction of rat liver by both phenobarbitone and 
3-methylcholanthrene. In contrast, reduction of the polar compound 
CB10-252 was not increased by either agent.
A similar dependence of activity upon substrate was noted by 
Albrecht et al. (1972), after rats had been fed a diet containing 
butter yellow. This regime decreased the azoreductase activity of 
the post-mitochondrial supernatant when butter yellow was used as 
substrate, which correlated with the depression observed in 
cytochrome P-450 content and NADPH-cytochrome c (P-450) reductase 
reported by other authors after oral administration of this 
compound (Autrup et al., 1975; Autrup and Warwick, 1975). However, 
when the polar azo dye amaranth was used as substrate, the azo­
reductase activity was increased in livers from animals fed butter yellow 
(Albrecht et al., 1972),
Studies utilising 2,4-dichloro-6-phenoxyethylamine (DPEA) and 
0-diethylaminoethyldiphenylpropyl acetate (SKF 525A), two inhibitors 
of the oxidative metabolism of cytochrome P-450 dependent monooxygenase 
reactions, demonstrated that these compounds influenced the 
in vitro activity of the microsomal azoreductase. SKF 525A stimulated 
anaerobic neoprontosil reduction, while DPEA inhibited this activity 
(Shargel and Mazel, 1972). However, neither compound altered the 
activity of the carbon monoxide insensitive (flavoprotein-mediated) 
azoreductase activity, or had any effect on neoprontosil reduction by a
partially purified preparation of NADPH-cytochrome c (P-450) reductase. 
Induction with phenobarbitone increased the proportion ;, of the 
azoreductase that was sensitive to DPEA inhibition and SKF 525A 
stimulation. In contrast, 3-methylcholanthrene pretreatment decreased 
this sensitivity to DPEA inhibition and SKF 525A stimulation. The 
carbon monoxide insensitive route induced by phenobarbitone or 
3-methylcholanthrene was insensitive to modification by DPEA or 
SKF 525A. These authors (Shargel and Mazel, 1972) concluded that 
DPEA and SKF 525A influenced the reduction of cytochrome P-450 
since: (i) carbon monoxide blocked the effect of DPEA or SKF 525A
on neoprontosil reduction; (ii) DPEA and SKF 525A had no effect on 
the functionality of NADPH-cytochrome c (P-450) reductase, as assayed 
by the rate of reduction of cytochrome c and also had no effect on 
the carbon monoxide insensitive azoreductase; (iii) DPEA and 
SKF 525A had no effect on the azoreductase activity of partially 
purified NADPH-cytochrome c (P-450) reductase. These findings were ' 
in accord with the observations of Gigon et al_. (1969) that SKF 525A 
and DPEA Increased or decreased, respectively, the rate of electron 
transfer to cytochrome P-450. This may influence electron flow from 
this haenioprotein to the azo acceptor.
In contrast to these previous studies which indicated that a 
multienzyme system was responsible for neoprontosil reduction, more 
recent work with the water-soluble azo dye amaranth suggested that 
the hepatic microsomal reduction of polar dyes was entirely dependent 
upon cytochrome P-450 (Fujita and Peisach, 1977a; 1978a, b). Thus, 
carbon monoxide inhibited azo dye reduction almost completely,
2while the level of activity in rat and mouse microsomal fractions . 
varied in direct proportion to the levels of cytochrome P-450 and 
cytochrome P-448 following induction with phenobarbitone and 
3-methylcholanthrene (Fujita and Peisach, 1978a). Amaranth 
reduction was inhibited by carbon monoxide by more than ninety-five per­
cent, even after induction, which argues against a substantial role for 
NADPH-cytochrome c (P-450) reductase.
Early suggestions for such a flavoprotein-mediated activity were 
based upon studies using flavin-depleted microsomes (Mueller and 
Miller, 1948). However,* flavin depletion may impair electron transport 
from NADPH to cytochrome P-450 and interfere with the performance of 
this haemoprotein during the transfer of electrons to azo compounds.
The identification of a carbon monoxide insensitive activity by 
subsequent workers (Hernandez et al., 1967b; Shargel and Mazel, 1968; 
1972; 1973; Autrup et al., 1975) was taken as a further indication ’ 
of an azo compound-flavoprotein interaction. However, such observations 
may be the result of incomplete inhibition of the haemoprotein with 
carbon monoxide, allowing some residual cytochrome P-450 dependent 
activity to express itself.
In addition to these microsomal systems, several cytosolic, oxygen- 
insensitive azoreductase activities have been identified capable of 
reducing drazoxolon (Daniel, 1969), CB10-252 (Autrup and Warwick, 1975) 
and methyl red (Huang et al., 1979). These additional pathways make 
the interpretation of some earlier studies open to speculation, since 
those workers using whole liver homogenates and post-mitochondrial
supernatant fractions as a source of enzyme would observe activities 
dependent upon the substrate used and the amount of oxygen present 
in the incubation medium.
1.9- The role of flavins in the reduction of azo compounds
The initial observation that flavins participated in the reduction 
of azo dyes was made by Mueller and Miller (1950) who demonstrated 
increased reduction of butter yellow when FAD was added to microsomal 
incubations. A similar enhancement of prontosil reduction was 
reported by Fouts et al. (1957) with riboflavin, FMN and FAD. Since 
these reports, flavin stimulation of mammalian azoreductase activity 
is a well documented phenomenon (Shargel and Mazel, 1968; Ketterer et al., 
1970; Williams et al., 1970; Mallett et al., 1977, 1978; Fujita and 
Peisach, 1978b). It 1ms been proposed that soluble flavins act 
as electron carriers from the azoreductase enzyme(s) to the azo 
substrate (Fouts et al., 1957; Gingell and Walker, 1971; Fujita and 
Peisach, 1978b). Chemical studies verified that dihydroflavins were 
capable of reducing azo compounds, with the concomitant generation of 
oxidised flavin (Gibian and Baumstark, 1971; Fujita and Peisach, 1978b). 
Complete reduction of mono-azo dyes proceeded with a stoichiometry of 
2 mol dihydroflavin oxidised per mol of azo compound reduced, indicating 
a four electron transfer to the azo dye (Gingell and Walker, 1971;
Fujita and Peisach, 1978b).
Flavin supplementation also stimulated the activity of the microbial 
azoreductase (Roxon et al., 1967; Scheline et al., 1970) where the 
effect of inhibitors was consistent with the interaction of soluble
flavin with NAD (P)H-dependent flavoproteins, and the non-involvement 
of cytochromes (Gingell and Walker, 1971). In common with the 
mammalian azoreductase, semi-purified microbial preparations capable 
of reducing azo dyes also possessed cytochrome c reductase activity. 
This suggested that soluble flavins act as electron transfer shuttles 
from NAD(P)H-dependent flavoproteins to the azo acceptor (Gingell and 
Walker, 1971).
Evidence that a similar system was operative after flavin 
stimulation of the mamalian azoreductase came from the observations 
of Shargel and Mazel (1972) utilising the cytochrome P-450 mono­
oxygenase inhibitors DPEA and SKF 525A. These two materials inhibited 
or stimulated, respectively, the rate of microsomal neoprontosil 
reduction under nitrogen. However, the inclusion of FMN in the 
system gave increased azoreduction in the presence of DPEA, while 
FMN and SKF 525A resulted in an increase in activity which was 
greater than that recorded with either compound alone. In addition, 
flavins increased the rate of neoprontosil reduction mediated by a 
partially purified preparation of NADPH-cytochrome c (P-450) reductase 
(Shargel, 1967), while the flavin supplemented microsomal azo­
reductase activity was insensitive to inhibition by carbon monoxide 
(Mallett et ad., 1977; Fujita and Peisach, 1978b). These observations 
appear to be consistent with soluble flavins interacting with NADPH- 
cytochrome £ (P-450) reductase, with a decreased dependence of azo­
reductase activity upon cytochrome P-450.
The concentration of riboflavin in rat hepatic tissue is 
about 25 yM (Long, 1961), and this may be available to function 
as an electron shuttle from microsomal electron transport components to 
azo compounds in vivo. This may have important consequences for the 
whole animal, as noted with the modifying effects of riboflavin on 
the carcinogenicity of butter yellow (Miller et al., 1948;
Kensler, 1949). High levels of dietary flavin led to an increased 
reduction of butter yellow in vitro (Kensler, 1949; Williams et al., 
1970), a pathway which decreased the production of carcinogenic 
metabolites (Kadlubar et al., 1976).
The studies presented in this dissertation seek to clarify which 
microsomal electron transport components are involved in the 
anaerobic, NADPH-dependent reduction of the polar azo compound 
amaranth. The interaction of soluble flavins with this system is also 
reported.
Chapter 2
DEVELOPMENT AND APPLICATION OF A CONTINUOUS 
ASSAY FOR THE ESTIMATION OF HEPATIC MICROSOMAL
AZOREDUCTASE ACTIVITY
2.1. Introduction
Many azo compounds undergo enzymic reductive cleavage to yield 
their component primary amines both in microbial and mammalian systems* 
(Walker, 1970; Mitchard, 1971). Two major pathways have been described 
in the hepatic microsomal fraction from the rat, corresponding to 
azoreductase activity mediated by NADPH-cytochrome £ (P-450) reductase 
or cytochrome P-450 (Hernandez et al., 1967a,b).
Anaerobic conditions are necessary for maximal activity (Fouts 
et al., 1957), to prevent the spontaneous reoxidation of partially 
reduced products foimed during this reaction (Gingell and Walker, 1971; 
Mason et al., 1978). Previous workers attempted to achieve this end 
by the use of inert gas£SJ to displace oxygen from the incubation 
medium (Hernandez et al., 1967a, b; Williams et al, 1970; Shargel 
and Mazel, 1972). However, even this precaution resulted in a 
variable lag period prior to the initiation of dye reduction (Walker 
et al., 1971). Thus, the fixed time assays routinely used by other 
workers (Hernandez et al., 1967a, b; Williams et al., 1976; Shargel and 
Mazel, 1972) provided no indication when dye reduction commenced and 
thereby lead to inaccurate estimations of azoreductase activity.
In these studies, the reduction of amaranth (a water soluble 
naphthylazonaphthol food colouring) by the rat hepatic microsomal 
fraction was followed spectrophotometrically. This method allowed the 
accurate visualisation of the lag period prior to the commencement of 
dye reduction. Further, the inclusion of an enzymic oxygen-scavenging 
system decreased the oxygen-tension of the system and allowed the
expression of azoreductase activity without the lengthy lag-period 
previously mentioned.
2.2. Materials
NADPH, NADH, FMN, FAD, riboflavin, bovine serum albumin, glucose
6-phosphate, glucose oxidase, catalase and glucose 6-phosphate
dehydrogenase were purchased from the Sigma Chemical Company, Poole,
+
Dorset? NADP was bought from the Boehringer Corporation, Londop-; 
sodium hydroxide, sodium carbonate, copper sulphate, sodium-potassium 
tartrate, sodium dithionite and Folin-Ciocalteau reagent were purchased 
from BDH.Ltd,Poole, Dorset; EDTA, glucose, sucrose, potassium chloride, 
disodium hydrogen orthophosphate and sodium dihydrogen orthophosphate 
were "Analar" grade from the same suppliers;* oxygen-free nitrogen was 
supplied by BOC, Crawley, Sussex.
The azo compounds used throughout these studies were donated by 
Williams Ltd., Hounslow, Middlesex.
2.3. Animals
Wistar albino rats (Porton strain), weight range 180 - 220g were 
used in all experiments. Animals were housed in polypropylene cages 
on sawdust bedding, and fed Spillers No. 1 Diet (Spillers Ltd., Barking, 
Essex) ad libitum. The temperature and relative humidity of the experi­
mental rooms were maintained at 22° and 50% respectively. The lighting 
cycle was 0630 - 1830h.
2.4. Isolation of microsomal fraction from rat liver
Animals were fasted overnight for 18h to reduce liver glycogen 
(Mazel, 1972) and killed by cervical dislocation. The liver was 
immediately excised and placed in approximately 30 ml of ice-cold 
50 mM sodium phosphate buffer, pH 7.4, containing 0.25 M sucrose and 
1 mM EDTA. A liver homogenate was prepared by suspending the whole 
tissue in ice-cold sucrose-EDTA-phosphate buffer (1 g of tissue to 
4 ml of medium) using four return strokes of a glass Potter-Elvehj an 
homogeniser (size c) fitted with a Teflon pestle, power driven at 
2950 rev./min. Cooling of the system was facilitated by a jacket 
containing a mixture of ice and water.
The liver homogenate was then centrifuged at 14,000 g^y for 20 min 
in the 8 x 50 ml rotor of a M.S.E. High Speed 18 centrifuge, cooled to 
4°, to I •> nuclei and mitochondria. The pelleted material
was discarded and the supernatant fraction centrifuged at 177,700 g^y 
for 35 min in the 8 x 25ml rotor of a Beckman L5-65 ultracentrifuge, 
cooled to 4°, to sediment the microsomal fraction. The supernatant 
was discarded and the microsomal pellet resuspended in ice-cold 50 mM 
sodium phosphate buffer, pH 7.4, containing 0.15 M potassium chloride 
and 1 mM EDTA, and resedimented at 177,700 g^y for 35 min. The washed 
pellet was then resuspended in ice cold 50 mM sodium phosphate buffer 
pH 7.4, containing 1 mM EDTA, to a protein concentration of approximately 
4 mg microsomal protein per ml. This stock suspension was stored on 
ice until required.
2.5. Estimation of protein content
The protein content of stock microsomal samples was estimated 
by the method of Lowry et al., (1951). Samples were diluted to 
approximately 150 yg protein/ml with 0.5 M NaQH, Aliquots of 0.5 ml 
wTere then diluted with 5 ml of fresh Lowry reagent (2% Na^ 00^;
1% CuSO^; 2% Na/K tartrate 100:1:1 by vol.) and allowed to stand
for 10 min at room temperature. After this time, 0.5 ml of 501 
(v/v) Folin-Ciocalteau reagent was added to each sample and well 
mixed. Standards (bovine serum albumin, 0-250 yg/ml in 0.5 M NaOH) 
were treated in parallel. After 40 min the absorbance at 720 nm was 
determined on a Cecil 272 spectrophotometer.
2.6. Development of a continuous assay to measure microsomal 
azoreductase activity
Preliminary studies
The azoreductase activity of the microsomal fraction was investigated 
using amaranth (the trisodium salt of 3-hydroxy-4 |(4-sulpho-l-naphthylalenyl) 
azoj-2,7-napthalene disulphonic acid) as substrate and NADPH as cofactor.
The reaction was performed in stoppered, 1 cm pathlength cuvettes 
containing a reaction volume of 3.5 ml 50 mM sodium phosphate buffer, 
pH 7.4. The test cell contained stock microsomal fraction (final 
concentration approximately 1 mg/ml), NADPH (final concentration 0.3 mM) 
and amaranth (final concentration 75 yM). Amaranth was omitted from 
the reference cell and replaced by an equal volume of buffer. The 
assay was performed in a Pye-Unicam SP1800 spectrophotometer, thermo- 
stated at 37°, by following the decrease in absorbance at 520 nm (X max) 
for amaranth). The substrate"- concentration employed in these
investigations allowed the reaction to be followed with maximal 
sensitivity without the spectrophotometer reading "off-scale”.
Under these conditions, initially the extinction decreased very 
slightly with time. However, after approximately 15 min of incubation, 
the extinction of the ”test cell” began to decrease more rapidly, 
suggesting an increase in the rate of dye reduction. This lag- 
period prior to the initiation of dye reduction could be reduced to 
8 - 1 0  min by saturating all the solutions used with oxygen-free 
nitrogen, suggesting that this initial lad< of activity was due to oxygen 
inhibition of the system (Hernandez et al., 1967a; Mason etal., 1978).
A more efficient reduction in the oxygen tension of the system 
utilised the oxygen scavenging properties of glucose oxidase (Matsubara 
et al., 1976). Thus, the inclusion of glucose oxidase (2-20 U/ml) 
catalase (0-3,000 U/ml) and glucose (60 mM) with the microsomal 
fraction and NADPH during preincubation dramatically reduced the 
lag-period such that dye reduction commenced 15 - 20 s after the 
addition of the azo substrate.
Azoreductase assay syston
In subsequent studies, the following conditions were used to 
determine the azoreductase activity of the hepatic microsomal fraction, 
with minor modifications to the previously reported method (Mallett 
et al., 1977). Determinations were carried out in stoppered cuvettes 
of 1 cm pathlength, with a Pye-Unicam SP1800 recording spectrophotometer 
equipped with a cell holder thermostated to 37°. The test cell contained
■f
0.5 - 1.0 mg/ml of microsomal protein, 0.5 mM NADP , 6 mM glucose
6-phosphate, lU/ml glucose .6-phosphate dehydrogenase, 10 U/ml 
glucose oxidase, 3,OCX) U/ml catalase, 60 mM glucose and 75 yM 
amaranth in 3.5 ml of 50 mM sodium phosphate buffer, pH 7.4. All 
solutions were equilibrated with oxygen-free nitrogen for 40 min 
prior to use. The NADPH-generating system was omitted from the 
reference cuvette, and replaced with an equal volume of buffer.
The microsomal fraction, NADPH-generating system and glucose
oxidase system were incubated at 37° for 5 min prior to the addition
oof a nitrogen-equilibrated solution of amaranth, also at 37 . The
headspace of the cell was flushed with oxygen-free nitrogen, stoppered
and dye reduction monitored at 520.nm. The enzymic activity was
determined from the initial linear fall in absorbance, using an
-1 -1extinction coefficient of 27.32 litre, mmol . cm (data supplied by 
the manufacturer).
The rate of dye disappearance under these conditions was found 
to be the combined activity of two separate reductive processes. One 
of these was ascribable to the microsomal fraction, while the other 
minor activity represented a non-microsomal, non-enzymic dye reduction 
mediated by the NADPH-g ener a ting system. This latter reaction m s  
determined by omitting the microsomal fraction from the assay. The 
activity due to the microsomal fraction was calculated by subtracting 
this NADPH-mediated rate from the total recorded rate.
The stoichiometry of electron transfer within this system was 
determined by measuring the microsomal reduction of amaranth (75 yM) 
at 520 nm concomitantly with the oxidation of NADPH (0.3 mM) at 340 nm.
The decrease in absorption at these wavelengths was followed 
alternately for short periods (approximately 7 s) during the course 
of the reaction. The endogenous oxidation of NADPH by the system 
in the absence of amaranth was determined separately, and subtracted 
from the rate of NADPH oxidation present in the complete system. The 
extinction coefficient for NADPH used in these calculations was 
6.20 litre, mmol  ^cm.  ^ (Dawson et ad., 1969). Statistical significance
was calculated by a paired t-test using an Olivetti P652 desk top 
computer, with programme 9200171,
2.7. Determination of the oxygen content of the assay system during 
azoreduction
A Rank Brothers oxygen electrode fitted with a thermostated C37°) 
reaction cell of 3.5 ml and equipped with a Heathkit multi-speed servo 
chart recorder, Model 1R-18, was used in these studies. A sample of 
50 mM sodium phosphate buffer, pH 7.4 was saturated with atmospheric 
oxygen after stirring in an open beaker for 40 min at 37 , and was used 
to calibrate the electrode. The zero point was obtained by the addition 
of a small amount of sodium dithionite to the reaction chamber. The 
chamber was then drained and washed three times with distilled water.
An aliquot (3.5 ml) of 50 mM sodium phosphate buffer, pH 7.4, well 
saturated with oxygen free nitrogen for 40 min was then introduced 
into the cell, and the relative oxygen content determined. The oxygen 
content of the azo-reductase assay system was investigated by adding 
the prewarmed components of the system to the reaction chamber and 
observing the initial relative oxygen concentration at the start of the 
reaction. The rate of oxygen disappearance was recorded, along with
the length of time required for the system to become anaerobic.
These results were contrasted with the oxygen content of the system 
in the absence of glucose oxidase, glucose and catalase. A value 
of 200 yM was used for the concentration of oxygen in the buffer at 
37° (Robinson and Cooper, 1970).
2.8. Influence of supplementary flavin, on hepatic microsomal 
azoreductase activity
The effect of added flavin on hepatic microsomal azoreductase 
activity was investigated by including FMN (0 - 500 yM) in the assay 
system. The flavin (equilibrated to 37 ) was introduced into the 
cuvette immediately after the addition of amaranth, and the rate 
of dye reduction monitored at 520 nm (2.6). A comparison of the 
effects of FAD, FMN and riboflavin (0, 100 , 300 and 500 yM) on azo­
reductase activity was undertaken.
The rate of dye reduction at 520 nm in the presence of 300 yM 
FMN was compared with the rate of FMN reduction at 445 nm in the
-1
absence of amaranth. An extinction coefficient of 12.5 litre, mmol . 
cm”  ^ (Dawson et al., 1969) was used to calculate the rate of FMN 
reduction, the reduced flavin having no absorbance at this wavelength 
(Koziol, 1971).
2.9. Variation of azoreductase activity with microsomal protein 
content
The absolute dependence of the rate of dye reduction on the final 
concentration of microsomal protein was determined in the absence or
presence of supplementary flavin (300 v M FMN) after correction for 
non-microsomal reduction mediated by the NADPH-generat ing system.
The conditions of the assay were as described in 2.6.
2.10. Comparison of NADH and NADPH as cofactor for the hepatic 
microsomal reduction of amaranth
The rate of the NADPH-dependent reduction of amaranth in the 
absence or presence of 300 y M FMN was compared with the rate of 
dye reduction with NADH as cofactor. The NADPH-dependent studies 
utilised a NADPH-g ener at ing system as described in 2.6. NADH- 
dependent activity was determined under similar conditions, with 
1 mM NADH as cofactor. In addition, the influence of the simultaneous 
inclusion of NADH and NADPH in the assay system was investigated.
2.11. Influence of amaranth concentration on hepatic microsomal , 
azoreductase activity in the presence and absence of supplementary 
flavin
The reduction of amaranth over a range of concentrations (25 - 500 yM) 
was followed at 37° as described, previously (2.6), with minor modifi­
cations. Miniature stoppered cuvettes of pathlength 2 mm were 
utilised in order to overcome the large absorbance encountered at 
substrate concentrations greater than 75 yM amaranth. The concentration 
of all the other components remained as described in 2,6. The azo­
reductase activity for each concentration of azo substrate was 
estimated in the presence of 0 to 500 yM FMN. The final volume of 
the assay m s  0.7 ml 50 mM sodium phosphate buffer, pH 7.4.
The data were plotted according to the method of Lineweaver 'and
Burk (Plowman, 1972), using an Olivetti P652 desk top computer with
linear regression programme 9200120 to determine the line of best
fit. The kinetic constants K and V were determined from them max
reciprocal of the intercepts on the x and y axes, respectively.
2.12. Influence of NADPH concentration on hepatic microsomal 
azoreductase activity in the presence and absence of supplementary 
flavin
The reduction of amaranth (75 yM) in the absence or presence 
of IMN C300yM) was determined over a range of NADPH concentrations 
by substituting this reduced cofactor for the NADPH-generating 
system described in 2.6. The microsomal fraction and glucose 
oxidase system were preincubated at 37° for 5 min prior to the 
introduction of amaranth, NADPH (20 - 200yM) and in appropriate 
cases FMN to give a final volume of 3.5 ml. The data were plotted 
according to the method of Lineweaver and Burk (Plowman, 1972), 
using an Olivetti P652 desk top computer with linear regression 
programme 9200120 to determine the line of best fit.
2.13. Comparison of azo'Substrates as electron acceptors during 
hepatic microsomalazoxiye reduction
The azoreductase activity of the microsomal fraction towards 
red 2G, red 10B, caxmoisine and ponceau 4R at a final concentration 
of 75 yM was compared with the reduction of amaranth under identical 
conditions to that described in 2.6. The absorbance maxima and 
extinction coefficients (provided by Williams of Hounslow) were as
follows:
Azo compound A max (nm)
Amaranth 520 27.32
Red 2G 532 31.56
Red 10B 530 31.64
Carmoisine 514 28.69
Ponceau 4R 506 25.17
The rate of reduction of each azo compound was determined in 
the absence and presence of 300 yM FMN.
2.14. RESULTS
The incubation of the microsomal fraction, NADPH and amaranth
initiation of azo dye reduction, which could be decreased when the 
assay buffer was saturated with nitrogen. These observations 
correlate with the reported oxygen-sensitivity of this reaction 
(Walker et al., 1971; Mason et al., 1978). Enzymic scavenging of 
oxygen has been successfully applied to another oxygen-sensitive 
reaction, namely the measurement of cytochrome P-450 reductase 
activity (Matsubara et al., 1976). Thus, the utilisation of glucose 
oxidase, glucose and catalase greatly decreased this initial 
inhibitory phase such that azoreduction commenced 15 - 20 s after 
mixing the assay components. As shown in Fig. 2.1 and Fig. 2.2 
neither glucose oxidase or catalase had any effect on the rate of 
dye disappearance, modifying only the initial lag-period. Glucose 
oxidase and catalase concentrations of 10 U/ml and 3,000 U/ml
at 37° resulted in a long and variable lag-period prior to the
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Influence of glucose oxidase concentration on hepatic 
microsomal azoreductase activity
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hepatic microsomal azoreductase activity
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Results represent the mean of triplicate determinations 
in the absence (o) or presence (©) of 300 yM FMN. 
Glucose oxidase and glucose concentrations were 10 U/ml 
and 60 mM respectively.
respectively were used in all subsequent experiments, together with 
60 mM glucose.
In the experiments in \v'hich an oxygen electrode was used to 
investigate the effect of various treatments on the oxygen status 
of the azoreductase assay system, it was found that saturation of the 
50 mM sodium phosphate buffer with oxygen-free nitrogen for 40 min. 
reduced the dissolved oxygen content of the solution to 16% of the 
saturated value. Assuming the oxygen saturated concentration to be 
200 yM (Robinson and Coopery 1970}, this corresponded to approximately 
32 yM. However, in a more realistic system where individual aliquots 
of buffer were mixed together in the sample chamber to represent the 
individual components of the assay system, a value of approximately 
88 yM oxygen was obtained. The inclusion of the glucose oxidase 
system and microsomal fraction in this model resulted in approximately 
98 nmol of oxygen being consumed per minute. However, this uptake> 
was not linear, and tended to decrease with the decreasing oxygen 
tension of the system. Oxygen consumption ceased after 2.25 min, 
when approximately 88% of the dissolved oxygen had been consumed, 
emission of the glucose oxidase system resulted in approximately 
36 nmol of oxygen being consumed per minute. Oxygen consumption 
ceased after 6.40 min, when about 70% of the initial oxygen content 
had been consumed.
Upon supplementation of the azoreductase assay system with soluble 
flavin, an increase in the rate of amaranth reduction was observed.
Over the range 0 - 5 0  y M FMN, azoreductase activity increased with 
increasing flavin concentration, with the system becoming saturated at
300 - 500 y M BIN. Supplementation with flavin also increased the rate 
of interaction between the NADPH-generating system and amaranth in 
the absence of microsomal protein (non-microsomal activity) (Fig. 2.3). 
However, this remained a minor component of the total azoreduction at 
all levels of FMN supplementation.
Riboflavin, FMN and FAD all displayed similar effects in increasing 
the azoreductase activity of the hepatic microsomal fraction 
(Table 2.1). However, at concentrations in excess of 100 pM, 
riboflavin was incompletely dissolved and thus no results are 
available for higher concentrations of this particular flavin. In 
comparison, the mono- and di-nucleotides were highly soluble and 
increased the rate of amaranth reduction to a similar extent. The 
system appeared to be largely saturated at 300 - 500 iM flavin.
Comparison of the rate of FMN reduction at 445 ran (38.40 - 0.80 
nmol/min/mg) with the disappearance of azo .substrate,at r520;.nm 
(18.47 - 0.44 nmol/min/mg) in a system supplemented with 300 uM FMN 
demonstrated that these two activities were equivalent on an electron 
basis, as complete reduction of flavin requires two electrons, while 
amaranth reduction is a four electron transfer. Thus, under these 
conditions, the rate of FMN reduction was the limiting factor 
controlling the transfer of electrons to the azo compound.
Under the standardised assay conditions, a microsomal protein 
concentration of 0,5 - 1.0 mg/ml m s  routinely-used. As shown in 
Fig. 2,4 the activity of the system varied in direct proportion to the 
final microsomal protein concentration up to approximately 2 mg/ml,
.Fig, 2.3.
Influence of FMN supplementation on
hepatic microsomal azoreductase activity
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(©) Microsomal azoreductase activity (nmol amaranth 
reduced/min/mg microsomal protein) corrected for 
non-microsomal reduction mediated by the NADPH-
generating system.
(a ) Non-microsomal'azoreductase activity (nmol amaranth 
reduced/min/ml assay medium) mediated by the 
NAJlPH-generating system:
Table 2.1.
Comparison of Riboflavin, FMN and FAD stimulation of 
hepatic microsomal azoreductase activity
Flavin supplemented azoreductase activity 
(nmol amaranth reduced/m in/mg microsomal
protein)
Flavin concentration Riboflavin 
(vM)
• FMN FAD
0 , ,3.00 - Q.~22
10 4,64 * 0.20 4.75 i 0.40 5.65 -
100 9.39. i 0.3S 9.97 i 0.40 9.50 -
300 - 18.47 t 0.44 19.06 i
500 — 21.23 - 1.38 21.80 -
Results represent the mean and S,Df for triplicate determinations 
corrected for non-microsomal reduction mediated by the NADPH-generating 
system.
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Fig. 2.4.
Variation of hepatic microsomal azoreductase 
activity with microsomal protein concentration
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Results represent the mean of triplicate determinations 
in the absence (o ) or presence (©) of 300 yM FMN and 
coriected for non-microsomal reduction mediated by the 
NADPH-generating system.
after which the relationship deviated from linearity. This applied to 
activities determined both in the absence or presence of supplementary 
flavin (300 yM FMN).
Investigation of the stoichiometry of NADPH oxidation and 
amaranth reduction demonstrated that these two processes were 
tightly coupled in the unsupplemented system (Table 2.2). After 
correction for the endogenous rate of NADPH oxidation in the absence 
of substrate, excellent correlation was obtained between NADPH 
oxidation and amaranth reduction. However, it was not possible to 
determine this relationship for the flavin supplemented system 
because of spectral overlap between NADPH and FMN at 340 nm.
Comparison of NADPH and NADH as cofactors during the reduction of 
amaranth by the hepatic microsomal fraction from the rat indicated 
that NADPH was the more efficient reductant for this reaction 
(Table 2.3). In the absence of flavin, the NADH-dependent activity 
was 601 of the activity present with the NADPH-generating system. 
Addition of 300 yM FMN to the assay system resulted in the NADH- 
dependent azoreductase possessing only 16% of the activity recorded 
when NADPH was cofactor (Table 2.3). Inclusion of both reduced 
pyridine nucleotides in the assay system produced no increase 
in activity.
The influence of NADPH concentration on the rate of amaranth 
reduction was determined as shorn in Fig. 2.5. At concentrations of 
NADPH up to 25 yM, the rate of dye reduction increased sharply with
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Table 2.3
Comparison of NADH and NADPH as electron donors 
during the hepatic microsomal reduction of amaranth
Azoreductase activity
(nmol amaranth reduced/min/mg/ 
microsomal protein)
Non-FMN supplemented FMN supplemented
NADPH generating system 3.17 - 0.41 13.42 * 1.06
NADH (l.OmM.) 1.91 - 0.24 2.16 - 0.24
NADPH generating system
plus NADH 2.16 - 0.24 13.83 -AL.42
Activities determined with either a NADPH-generating system 
(0.5 mM NADP'Jv 6 mM glucose 6-phosphate, 1 U/ml glucose 6-phosphate 
dehydrogenase) or ^ 1-mM'NADH' cofact oi; in the absence or presence of 
300 yM FMN.
Results represent the mean and S.D. of triplicate determinations after 
correction for non-microsomal reduction mediated by- the reduced 
cofactor.
increasing cofactor concentration, both in the absence and presence 
of supplementary FMN. The enzyme(s) responsible for azoreduction 
appeared to reach saturation at 100 yM NADPH (Fig. 2.5).
The kinetic constants for these processes indicated that the
non-flavin supplemented system had an apparent Km of 15 yM NADPH,
with a V of 5 nmol amaranth r educ ed/m in/mg microsomal protein max
(Fig. 2.6). Addition of 300 yM FMN to the system increased 
by over four fold to 22 nmol amaranth reduced/min/mg microsomal protein, 
with a concurrent increase in the apparent to 40 yM NADPH. Thus, 
three times the concentration of NADPH was required to give half 
maximal velocity when 300 yM FMN was present in the assay system.
The azoreductase activity of the microsomal, fraction varied with, 
the final concentration of amaranth present in the assay system. A 
Lineweaver-Burk plot of this data indicated an apparent of 
30 yM amaranth, and a of 4 nmol amaranth r educ ed/m in/mg 
microsomal protein for the non-flavin supplemented activity 
(Fig. 2.7). Flavin supplementation decreased the apparent Km for 
amaranth with a concomitant increase in the maximal activity of 
the azoreductase.
A double reciprocal plot of FMN-stimulated azoreductase activity 
versus FMN concentration resulted in biphasic kinetic plots 
(Fig. 2.8), These plots were characterised by a phase present at 
low concentrations of FMN (less than 50 yM) possessing a low K and 
a low Vmax (the "slow phase") and a phase present at high FMN
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Fig. 2.5.
Influence of NADPH concentration on 
hepatic microsomal azoreductase activity
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Results represent the mean of triplicate estimations
in the absence .(O) or presence (©) of 300 yM FMN and 
are corrected for non-microsomal reduction mediated by
the NADPH-generating system.
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Fig- 2 .8 .
Influence of amaranth and flavin concentration on 
the kinetics of hepatic microsomal azoreductase activity
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Fig, 2,8. continued
0.121
0.10"
0.08-
500 yM amaranth
0.080.04
y nmol anjaran.tlx reduced/min/mg microsomal protein 
s yFMN
Results- represent the mean of triplicate determinations 
corrected for non~microsomal reduction mediated by the 
NADPH-generating system.
concentrations (greater than 50 yM) possessing a high K and a
high V (the Mfast phase") (Table 2.4). However, both phases
were dependent upon the concentration of the azo substrate for
their kinetic constants. Thus, increasing the amount of
amaranth present in the assay decreased the for both the "slow
phase'1 and the "fast phase", while leaving the V values unchanged
max
(Table 2,4). These variations in reflected changes in the 
concentration of FMN required to give half the maximal velocity.
A tenfold increase in amaranth concentration decreased the 
of the "slow phase" by over one third, while the same range of 
azo dye concentrations reduced the "fast phase" by one half.
Experiments with a number of watersoluble compounds indicated 
that the majority were reduced at rates similar to amaranth, with 
the exception of red 10B (Table 2.5), This compound was reduced 
much more slowly than the structurally related dye red 2G. A
\
similar result was reported with the microbial azoreductase 
(Walker and Ryan, 1971) where it was postulated that internal 
hydrogen bounding resulted in the increased stability of red 10B 
to reduction (Fig. 2.9).
2.15. DISCUSSION
The method presented here for investigating the azoreductase 
activity of the rat liver microsomal fraction allows a continuous and 
rapid estimation of activity compared with previous procedures (Mueller 
and Miller, 1950; Hernandez et al., 1967a, b; Williams et al., 1970;
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Table 2.5
Comparison of azo substrates as electron acceptors
during hepatic microsomal azo dye reduction
Azo substrate 
(75 pM)
Azoreductase activity 
(nmol/min/ing protein)
Non-FMN supplemented FMN supploriented
Amaranth 
Red 2G 
Red 10B 
Carmoisine 
Ponceau 4R
3.04 - 0.17 
2.48 - 0.06
0.48 - 0.06
2.71 - 0.34 
2.95 - 0.17
14.12 - 0.63 
16.73 -'1.40
4.51 -"'0.54
13.80 -"0.61 
14.50 -"1.24
Results represent the mean and S.D. of triplicate estimations corrected 
for non-microsomal azoreduction due to the NADPH-generating system, 
in the absence or presence of 300 yM FMN.
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Fig. 2.9.
Stabilisation of red 1QB by hydrogen bonding 
between the B-azo nitrogen and the naphthol group
Shargel and Mazel, 1972). The inclusion of glucose, glucose oxidase 
and catalase in these studies facilitated the rapid removal of 
oxygen from the assay system and permitted the full expression 
of microsomal azoreductase activity.
Flavin supplementation studies indicated that FAD, FMN and 
riboflavin all increased the NADPH-dependent azoreductase activity 
of the microsomal fraction towards a number of water soluble mono- 
azo compounds. It has been proposed that soluble flavins may, under 
anaerobic conditions, act as electron shuttles between reductive 
enzymes and artificial acceptors such as azo dyes (Fouts etal., 1957 
Gingell and Walker, 1971). However the mechanism of this stimulation 
is unclear, since double reciprocal plots of azoreductase activity 
versus flavin concentration possessed biphasic characteristics 
suggesting a complex substrate/enzyme interaction (Alvares and 
Mannering, 1970; Pederson and Aust, 1970). In contrast, a 
Lineweaver-Burk plot of flavin supplemented azoreductase activity 
versus amaranth concentration yielded a linear relationship at a 
given concentration of flavin.
The enzyme (s) responsible for this reduction of amaranth showed 
greater activity when NADPH was cofactor, compared with NADH, In the 
presence of high levels of supplementary flavin, the NADH-supported 
azoreduction wash. / a fraction of the activity observed with a 
NADPH-generating system. In comparison, a large proportion of 
activity remained in the unsupplemented system when NADIi was 
substituted for NADPH, Similar findings were reported by
Hernandez et al., (1967b) for the NADH-dependent reduction of
neoprontosil. This suggests the involvement of the NADH- 
cytochrome reductase/cytochrome b^ electron transfer chain, 
as reported by other workers (Fujita and Peisach, 1977b).
Ifowever, no synergistic increase in activity was observed when 
both pyridine nucleotides were present in the same system.
Azo dye reduction is tightly linked to NADPH oxidation in the 
absence of supplementary flavin, as demonstrated by the stoichiometry 
of this system. In the presence of supplementary FMN, NADPH 
oxidation at 340 nm was an unreliable monitor of cofactor 
utilisation due to spectral overlap between the flavin and 
reduced pyridine nucleotide and’therefore it was not possible to 
assess the stoichiometry. In the presence of large amounts of 
soluble flavin, the apparent for NADPH was three fold greater 
than that determined for the non-supplemented azoreductase activity.
The inferences which can be made with regard to the mechanism 
of this flavin stimulation of hepatic microsomal azoreductase 
activity and the identity of the enzyme(s) responsible, will be 
discussed more fully in the light of further data.
'Chapter 3
THE INFLUENCE OF CYTOCHROME P-450 LIGANDS 
AND SUBSTRATES ON THE HEPATIC MICROSOMAL REDUCTION
OF FLAVIN AND AMARANTH in vivo
3.1. Introduction
The assay developed and described in Chapter 2 was used in 
studies to determine which microsomal components were involved 
in the anaerobic, NADPH-dependent reduction of amaranth in the 
absence and presence of supplementary flavin. Compounds known to 
interact with cytochrome P-450 during oxidative drug metabolism 
were utilised to elucidate the role this haemoprotein played in 
amaranth reduction. Thus, carbon monoxide inhibits oxidative 
cytochrome P-450 catalysed mixed function oxidase-type reactions 
(Estabrook et al., 1970) and also inhibits a portion of anaerobic 
microsomal neoprontosil reduction (Hernandez et al., 1967a, b).
In addition, neoprontosil reduction is inducible with phenobarbitone 
and 3-methylcholanthrene and destroyed upon solubilisation of the 
microsomal fraction with steapsin, further indications of the 
involvement of cytochrome P-450 (Hernandez et al., 1967a, b). A 
second pathway of neoprontosil reduction present in the microsomal 
fraction from normal animals was attributed to the carbon monoxide 
insensitive flavoprotein, NADPH-cytochrome £ (P-450) reductase 
(Hernandez et al., 1967a, b). However, studies using the highly 
polar food dye amaranth suggest that azoreductase activity may be 
totally inhibited by carbon monoxide, indicating a total dependence 
upon cytochrome P-450 (Fujita and Peisach, 1978a).
A number of investigators have shown that various compounds 
cause two types of changes in the visible absorption spectrum of
hepatic microsomal suspensions, in the absence of NADPH (Remmer 
et al., 1966; Schenkman et al., 1967). The "type I" difference 
spectrum is characterised by a trough at about 420 nm and a peak 
at about 385 nm, whereas the ’’type II" difference spectrum 
possesses absorption maxima and minima at approximately 430 nm and 
394 nm, respectively. These interactions are thought to 
represent complexes of cytochrome P-450-substrate (Gigon et al., 
1969). The addition in vitro of chemical compounds which produce 
type I spectral changes markedly accelerate the rate of anaerobic 
NADPH-dependent cytochrome P-450 reduction, while the addition of 
compounds which elicit type II spectral changes significantly 
decelerate the rate of haemoprotein reduction (Gigon et al,, 1969). 
As azo dye reduction . may be partially (Hernandez et al., 1967a, b) 
or totally (Fujita and Peisach, 1978a) dependent upon cytochrome 
P-450 for activity, the addition of type I or type II substrates 
may modify the activity of the azoreductase in a manner analogous 
to the stimulation or inhibition observed with cytochrome Pr450 
reductase activity.
The experiments reported in this chapter investigated this 
cytochrome P-450 dependent azoreductase pathway by the use of 
carbon monoxide, and a number of type I and type II compounds. 
Kinetic studies were undertaken to elucidate the mechanism involved 
in any interaction observed. The influence of these same compounds 
on flavin supplemented azoreductase activity and flavin reduction 
m s  investigated. The stimulation of the reduction of azo dyes 
by- soluble flavin may be due to the reduction of flavins by flavo-
protein(s), rather than cytochrome P-450 (Shargel, 1967; Fujita 
and Peisach, 1978b). If this suggestion is the case, interactions 
at the level of the haemoprotein should not influence this activity.
3.2. Materials
Dimethyl formamide was purchased from the Sigma Chemical 
Company, Poole, Dorset; potassium cyanide, aniline hydrochloride 
and biphenyl were supplied by BDH Ltd., Poole, Dorset; hexobarb- 
itone and ethylmorphine were a gift from May and Baker, Dagenham, 
Essex; metyrapone was supplied gratis by Ciba Laboratories,
Horsham, Sussex; SKF 525A was donated by Smith, Kline and French 
Laboratories, Welwyn Garden City, Hertfordshire; oxygen-free 
carbon monoxide was purchased from BOC, Crawley, Sussex; 
n-octylamine was bought from the Aldrich Chemical Company, 
Gillingham, Kent; p-nitrophenetole was synthesised by Mr. T. Fennel 
of the Department of Biochemistry at the University of Surrey.
All other chemicals and reagents were as described previously.
3.3. Isolation of hepatic microsomal fraction
Male Wistar albino rats (180 - 200 g) were sacrificed by 
cervical dislocation and the hepatic microsomal fraction isolated 
as described in 2.4. Microsomal protein concentrations were 
determined as described in 2.5.
5.4. Influence of carbon monoxide on hepatic microsomal azoreductase
activity
The isolated microsomal fraction was divided into two samples 
and stood on ice. Carbon monoxide was bubbled through one aliquot 
for 15 min, while the control sample was treated with oxygen-free 
nitrogen for the same period. Solutions to be used in carbon 
monoxide studies were equilibrated with CO for 40 min, while control 
solutions were treated with nitrogen. Anaerobic azoreductase activity 
was determined as described in 2.6, after flushing the head space 
of the cuvette with carbon monoxide or nitrogen, as appropriate.
Statistical significance between carbon monoxide and nitrogen 
treatments was calculated on an Olivetti P652 desk top computer using 
t-test programme ST0706. Kinetic analysis of this data was 
performed by the method of Lineweaver and Burk (Plowman, 1972).
The line of best fit through the points was estimated using linear 
regression programme 9200120.
3.5. Influence of carbon monoxide on FMN supplemented azoreductase 
activity
The flavin supplemented azoreductase activity of the microsomal 
fraction was studied in a medium equilibrated with either carbon . 
monoxide or nitrogen (3.4) as described in 2.8. Analysis of the 
results was performed as described in 3.4.
3.6. Influence of carbon monoxide on microsomal flavin reduction
Anaerobic flavin reduction by the microsomal fraction was 
determined by a procedure similar to that used for the estimation 
of azoreductase activity (2.6), by substituting riboflavin, FAD 
or FMN (12.5 - 500 yM) for amaranth. Solutions were equilibrated 
with either carbon monoxide or nitrogen (3.4). In experiments 
utilising flavin levels in excess of 100 yM, 2 mm pathlength cells 
were used to overcome the large absorbance of these materials at
high concentration. An extinction coefficient of 11.30 litre.
—1 - 1  * 
mmol .cm at 450 nm was used for FAD, while FMN and riboflavin
reduction was monitored at 445 nm using an extinction coefficient
of 12.50 litre.mmol ^.cm * (Dawson et al., 1969). The results were
analysed as described in 3.4.
3.7. Influence of cytochrome P-450 ligands and substrates on 
hepatic microsomal azoreductase activity
The anaerobic reduction of amaranth by the microsomal fraction, in 
the absence or presence of 300 yM FMN (2.6; 2.8) was investigated in 
the presence of several cytochrome P-450 substrates. Hexobarbitone, 
fq-nitrophenetole, biphenyl, SKF 525A, ethylmorphine, octylamine, aniline 
or metyrapone were added to the test and reference cuvettes in 10 yl 
DMF, to give the desired final concentration (0 - 20 mM); potassium 
cyanide was introduced into the system in 0.1 ml buffer. These 
compounds were incubated together with the microsomal fraction, NADPH- 
generating system and glucose oxidase system at 37° for 5 min prior to the
addition of azo substrate or azo substrate and flavin. Analysis 
of the results was performed as described in 3.4.
3.8. Influence of cytochrome P-450 ligands and substrates on 
hepatic microsomal flavin reduction.
The anaerobic reduction of BIN (12.5 - 500 jiM) was investigated 
in the presence of several cytochrome P-450 ligands and substrates. 
The microsomal fraction, NADPH-generating system and glucose 
oxidase system were preincubated for 5 min at 37° with these 
compounds, and the flavin reductase activity determined (3.6).
The results were analysed as described in 3.4.
3.9. RESULTS
In the presence of carbon monoxide, the NADPH-dependent 
reduction of amaranth by the hepatic microsomal fraction was 
inhibited by about 10% over a wide range of azo substrate 
concentrations (Table 3.1). This inhibition was highly significant 
(P< 0.001) at all concentrations of amaranth investigated. A 
Lineweaver-Burk plot of this data (Fig. 3.1) apparently
non-competitive kinetics, with carbon monoxide decreasing the 
maximal velocity of amaranth reduction from 4 nmol/min/mg 
microsomal protein to 1 -nmol/min/mg microsomal protein. The 
apparent Kmwas largely unchanged, with the control and carbon 
monoxide inhibited experiments yielding values of 44 and 39 yM
Table 3.1.
Influence of carbon monoxide on hepatic microsomal
azoreductase activity
Amaranth . , . . . ..
Concentration ^ g ^ u c tase_actiyitx
, (nmol amaranth reduced/min/mg microsomal
 ^ ' protein)
Control Plus carbon monoxide
12.5 1.08
+
0.15 0.31 - 0 .02***
25 1.89
+
0.09 0.50 - 0 .02***
50 2.23
+
0.11 0.73 ~ 0 .02***
100 2.91
+
0.08 0.88 - 0.05***
150 3.32
+
0.11 0.99 t 0.04***
+ •f*
250 3.51 0.07 1.10 - 0.18***
500 3.82 0.15 1.23 - 0.06***
*** P < 0.001
Results represent the mean and S.D. of triplicate determinations 
after correction for non-microsomal reduction mediated by the 
NADPH-generating system.
69
amaranth respectively.
Upon supplementation of the assay system with soluble flavin, 
this sensitivity to carbon monoxide inhibition was greatly 
diminished (Table 3.2). Analysis of this biphasic data revealed 
apparently competitive inhibition, with both the Mslow phase” and 
the "fast phase" showing increases in of 35 - 40% of the control 
value, with V v remaining unchanged (Fig. 3.2; Table 3.3).
UloX
Microsomal FMN reduction also showed decreased sensitivity to 
carbon monoxide inhibition with increasing flavin concentration 
(Table 3.4). Analysis of these results gave a linear relationship 
between the reciprocals of FMN concentration and the rate of FMN 
reduction (Fig. 3.3). The presence of carbon monoxide resulted in 
apparent competitive inhibition of microsomal FMN reduction, 
with a three fold increase in apparent (yM FMN), while Vm 
(nmol FMN reduced/min/mg) remained constant.
The flavins FAD, FMN and riboflavin showed similar patterns of 
inhibition by carbon monoxide (Table 3.5). Riboflavin was reduced 
at a slower rate than the mono- and di-nucleotides at a concentration 
of 500 yM, which may reflect the incomplete solubility of this 
compound at this level.
The activity of the hepatic microsomal azoreductase was also 
influenced by compounds which bound to cytochrome P-450. Hexobarbitone, 
a type I cytochrome P-450 substrate, gave a concentration dependent 
stimulation of the non-flavin supplonented azoreductase activity 
(Fig. 3.4). Octylamine, a type II ligand, decreased the activity
Table 3.2.
Influence of carbon monoxide on FMN-stimulated
azoreductase activity
FMN concentration* Azoreductase activity
(nmol amaranth reduced/min/mg microsomal
Control
protein) 
Plus CO Plus CO/Control
15 6.08 - 0.31 5.02 - 0.15 ** 83%
25 7.66 - 1.07 6.51 - 0.15 851
50 9.40 - 0.55 8.56 - 0.43 91%
150 13.94 1
 +
o h-
1
13.59 - 0.31 97%
300 17.16 - 0.81 17.89 - 0.53.
oI—i
500 19.14 ~ 0.41 19.94 - 2.14 104%
** P < 0.01
Results represent the mean and S.D. of triplicate determinations 
corrected for non-microsomal reduction mediated by the NADPH- 
generating system.
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Fig, 3.2. •
Influence of carbon monoxide on flavin supplemented
hepatic microsomal azoreductase activity
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Results represent the mean of triplicate determinations in the 
absence (o) or presence (©) of carbon monoxide, after correction 
for non-microsomal reduction mediated by the NADPH-generating 
system.
v nmol amaranth reduced/min/mg microsomal protein
' O /
s pM FMN y
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Table 3.3
Influence of carbon monoxide on the kinetics of FMN-stimulated
azoreductase activity
"Slow Phase" "Fast Phase"
Km Vmax Km ymax
Control microsomes 15 12 93 23
Plus carbon monoxide 21 12 126 25
Vmax’ nmo '^ amaran't^  reduced/m in/mg microsomal protein
pM FMN
Table 3.4.
Influence of carbon monoxide on microsomal FMN reduction
Flavin reductase activity 
Flavin coneentration (nmol FMN reduced/min/mg microsomal protein)
(pM)
Control Plus CO +C0/control
12.5 7.98
+
0.48 3.11
+
0.09*** 391
15 9.38 0.21 4.36
+
0.13*** 461
25 13.06
+
0.48 6.33
+
0.43*** 48%
50 18.33
+
2.17 8.13 0.91** 44%
100 25.83
+
0.21 15.69 2.14** 61%
150 31.81
+
2.41 23.48 0.60* 74%
300 32.98
+
2.17 30.21
+
2.76 92%
500 34.38
+
3.61 38.54 2.08 112%
* P <0,05 ** P<0.01 *** P<0.001
Results represent the mean and S.D. of triplicate determinations 
corrected for non-microsomal reduction mediated by the NADPH- 
generating system.
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Fig- 3.3,
Influence of carbon monoxide on microsomal FMN reduction
maxm
Control 4 7
0.3-
Plus CO 135
0 . 1-
0.08 ^0.04
Results represent the mean of triplicate determinations in the 
absence (o) or presence (®) of carbon monoxide, after correction 
for non-microsomal reduction mediated by the NADPH-generating system. 
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Influence of hexobarbitone and octylamine on microsomal
azoreductase activity
■H
•H
■M
10 20
Hexobarbitone or octylamine 
concentration (mM)
Results represent the mean and S.D. :of triplicate determinations 
after correction for non-microsomal reduction mediated by the 
NADPH-generating system 
(©) control activity 
(a ) hexobarbitone 
(B ) octylamine
of the azoreductase (Fig. 3.4). Similar changes were observed 
in the FMN-supplemented azoreductase assay system (Fig. 3.5).
In common with hexobarbitone, the type I substrates 
g-nitrophenetole and SKF 52SA both resulted in a 15 - 20% 
increase in non-flavin supplemented azoreductase activity when 
present at a concentration of 10 mM (Table 3.6). These compounds 
also increased the flavin supplemented azoreductase activity, as 
did biphenyl and possibly ethylmorphine. In contrast, the type II 
ligands metyrapone, potassium cyanide and octylamine decreased 
the activity of both the non-supplemented and FMN supplemented 
azoreductase' activities (Table 3.7). Aniline, a compound possessing 
a mixed type I/type II character, resulted in a slight decrease 
in the non-flavin supplemented activity, but gave an increase in the 
activity of the flavin supplemented azoreductase.
The simultaneous addition of a type I and a type II substrate 
to the azoreductase assay resulted in a decrease in activity in 
both the non-supplemented and FMN-supplemented systems (Table 3.8). 
Thus, the stimulatory effects of hexobarbitone and biphenyl were 
negated when octylamine was present.
The kinetics of this stimulation or inhibition indicated that 
different mechanisms were operative in the absence or presence of 
FMN. Thus, biphenyl and hexobarbitone increased the maximal 
velocity of the non-flavin supplemented azoreductase, with no 
change in the apparent for amaranth (Fig. 3 .6; Table 3.9).
7a
 ^ Fig. 3.5.
Influence of hexobarbitone and octylamine on FMN-supplemented, 
microsomal azoreductase activity
.5 20-j
■po
2010
Hexobarbitone or octylamine 
concentration (mM)
Results represent the mean and S.D. of triplicate determinations 
in the presence of 300 pM FMN, after correction for non-microsomal 
reduction mediated by the NADPH-generating system.
(©) control activity 
( &) hexobarbitone 
(B ) octylamine
8 0
Table 3,6.
Influence of type I cytochrome P-450 substrates on hepatic 
microsomal azoreductase activity
Azoreductase activity 
(nmol amaranth reduced/min/mg microsomal protein)
Compound Non-flavin supplemented Flavin supplemented
Control activity 3.16 - 0.17 16.00 0.80
Control + 10 yl DMF 2.91 - 0.09 15.47
+
0.46
SKF525A 3.76 - 0.17* 17.07
+
0.46
Hexobarbitone - 22.67
+
1 .22**
9 -Nitrophenetole 3.66 i 0.09** 22.67
+
0.92***
Biphenyl - 20.54 2.31*
Ethylmorphine 18.14 1.22
* P<0.05 **P<0.01 *** P< 0.001
>
Results represent the mean and S.D. of triplicate determinations 
after correction for non-microsomal reduction mediated by the NADPH- 
generating system. Azoreductase activity was determined in the 
absence or presence of 300 yM FMN. Substrate concentration was 10 mM, 
added in 10 yl IMF.
5 ±
Table 3.7.
Influence of type II cytochrome P-450 ligands on hepatic
microsomal azoreductase activity
Azoreductase activity 
(nmol amaranth r educ ed/m in/mg microsomal protein)
Compound Non-flavin supplemented Flavin supplemented
Control activity
Metyrapone
Aniline
3.77 - 0.12 13.56 - 0.52
Potassium cyanide 
Octylamine
2.40 - 0.35** 
3.43 - 0.31 
3.05 - 0.15**
12.82 - 0.52 
16148..- 2.72
8.14 - 0.52***
2.00 - 0.31*** 7.73 - 1.05***
**P<0.01 *** P <0.001
Results represent the mean and S.D. of triplicate determinations after 
correction for non-microsomal reduction mediated by the NADPH-generating 
system. Azoreductase activity was determined in the absence or presence 
of 300 pM FMN. Substrate concentration was 10 mM. Aniline, metyrapone and 
octylamine were added in 10 pi IMF; potassium cyanide ■ was added in 
0.1 ml buffer.
Table 3.8.
Influence of type I and type II compounds on hepatic
microsomal azoreductase activity
Compound 
Control activity
Hexobarbitone
Octylamine
Hexobarbitone plus 
octylamine
Azoreductase activity 
(nmol amaranth reduced/min/mg microsomal protein)
Non-flavin supplemented
3.17 - 0.11
4.88 - 0.21***
1.65 - 0.36**
1.53 - 0.28***
Flavin supplemented
16.46 - 0.76
21.40 - 1.12**
9.98 - 0.56***
9.05 - 0.76***
Biphenyl
Octylamine
Biphenyl plus 
octylamine
5.06 - 0.37***
1.71 - 0.37**
2.20 - 0.18**
19.42 - 0.76**
10.53 - 0.56***
9.88 - 0.38***
** P <0.01 *** P <0.001
Results represent the mean and S.D. of triplicate determinations after 
correction for non-microsomal reduction mediated by the NADPH-generating 
system. Azoreductase activity was determined in the absence or presence 
of 300 pM FMN. Substrate concentration was 10 mM, added in 10 pi DMF.

Table 3.9.
Influence of biphenyl and hexo bar bitone on microsomal
FMN and azo dye reduction
Azoreductase activity FMN reductase activity
K V K V
m max m max
Control 27 . 3 113 48
Biphenyl (10 ieM) 27 5 31 32
Hexobarbitone (10 itM) 27 5 37 37
: yM amaranth or FMN.
V^ax : mnol substrate reduced/min/mg microsomal protein.
In contrast, the stimulation of hepatic microsomal FMN reduction
by type I compounds resulted from a decrease in Km (yM FMN) (Fig, 3.7;
Table 3,9). The decreased non-flavin supplemented azoreductase
activity seen in the presence of a type II substrate such as octyl-
amine resulted from a decrease in Vmax (nmol amaranth reduced/min/mg
microsomal protein) while (yM amaranth) remained constant
(Fig. 3.3). In contrast, octylamine and potassium cyanide inhibition
of microsomal flavin reduction was through a mechanism which increased
K without an alteration in V (Fig. 3.9; Table 3.10). m max °
3.10. DISCUSSION
The anaerobic, NADPH-dependent reduction of amaranth by the
microsomal fraction was inhibited by carbon monoxide in both the
absence and presence of supplementary flavin. The kinetics of the
non-flavin supplemented system were indicative of a non-competitive
interaction between carbon monoxide, amaranth and the azoreductase.
Similar non-competitive inhibition is observed during the aerobic
functioning of the monooxygenase (Estabrook et al., 1970). In
contrast, carbon monoxide competitively inhibited both the nslow
phase” and the "fast phase” of the flavin supplemented azoreductase
activity. This suggests that flavin and carbon monoxide compete
for a common site on cytochrome P-450 which must be involved in
both the high V and low V processes.& max max 1
That fraction of the non-flavin supplemented azoreductase activity 
that was inhibited by carbon monoxide is comparable with the carbon
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Fig. 3.8.
Influence of octylamine on hepatic microsomal azoreductase
activity
1.0 -
0.5-
0.08 ~0.04
Results represent the mean of triplicate determinations after 
correction for non-microsomal reduction mediated by the NADPH- 
g enera t ing syst em.
( □ ) control activity 
(ss) plus octylamine (10 mM)
v nmol amaranth reduced/min/mg microsomal protein 
s yM amaranth
i

Table 3.10.
Influence of octylamine and potassium cyanide on microsomal
FMN and azo dye reduction
Azoreductase activity FMN reductase activity
v_max Km Vmax
Control
Octylamine (10 mM) 
Potassium cyanide
43
43
37
107
83
20
23
19
K : yM amaranth or FMN. m
V ^ x  : m °l substrate reduced/min/mg microsomal protein,
monoxide sensitive pathway described by Hernandez et al_., (1967a, b) 
in studies on neoprontosil reduction. The residual activity was 
postulated to represent the interaction between the azo substrate 
and a second source of reducing equivalents, namely NADPH-cytochrome 
£ (P-450) reductase. Alternatively, this insensitive route may 
represent a haemoprotein-mediated activity which is less susceptible 
to carbon monoxide, as multiple forms of cytochrome P-450 with 
differing substrate specificities (Ullrich and Kremers, 1977;
Lu and West, 1978) and differing affinities for carbon monoxide 
(Comai and Gaylor, 1973) have been reported within the microsomal 
fraction. However, the linear double reciprocal plots obtained in 
these present experiments provide no evidence for more than one 
enzyme participating in the non-flavin supplemented reduction of 
amaranth. Thus, the apparent "carbon monoxide insensitive" azo- 
reductase activity observed in these studies will reflect the 
equilibrium between inhibited and non-inhibited forms of cytochrome 
Pr450, which will depend on the concentration of carbon monoxide present.
The introduction of compounds which are substrates or ligands 
for the monooxygenase activity of the cytochrome P-450 systan 
resulted in changes in anaerobic azoreductase and flavin reductase 
activities. Materials which are type I cytochrome P-450 substrates 
increased the non-flavin supplemented and flavin-supplemented azo­
reductase activity, and the rate of FMN reduction. In contrast, 
type II compounds decreased these same reductive microsomal 
activities. However, different mechanisms of stimulation and
inhibition were observed, dependent upon the presence or absence 
of flavin in the system.
Non-flavin supplemented azoreductase activity was modified by 
a change in the maximal rate of amaranth reduction, with remaining 
constant. Thus, type I compounds increased for this process, 
while type II compounds decreased this same kinetic constant. Also, 
type II ligands may non-competitively inhibit amaranth reduction, 
while type I compounds result in the apparent activation of the 
azoreductase. hmplicito in this latter observation is the 
assumption that type I substrates and amaranth interact at separate 
sites on cytochrome P-450, since a common site would result in the 
type I compound inhibiting azoreductase activity.
In contrast to these observations, FMN reduction was increased 
or decreased by type I or type II substrates respectively, due to 
alterations in for the system, with the ^ m3X remaining relatively 
constant. Thus, type II ligands appear to competitively inhibit 
flavin reduction, while type I compounds decrease the amount of 
flavin required to give half maximal activity, possibly through 
"allosteric activation” of the system. These observations again 
suggest a separate site of interaction of the type I compound and 
flavin with cytochrome P-450.
A similar stimulation or inhibition of neoprontosil reduction 
was observed by Shargel and Mazel (1972) when SKF 525A (type I) 
or DPEA, (type II) were added to microsomal azoreductase 'incubations.
Such modifications in azoreductase activity are in accord with 
the observation that type I substrates stimulate and type II compounds 
inhibit cytochrome P-450 reductase activity (Gigon et al., 1969; 
Matsubara et al., 1976). The binding of type I substrates to 
cytochrome P-450 results in the conversion of this haemoprotein into 
a predominantly high-, spin, state, with a concomitant increase in 
redox potential (Sies and Weigl, 1976; Sligar et al., 1979),
This results in increased electron flow from the flavoprotein 
reductase to the haemoprotein, thereby increasing the activity of the 
cytochrome P-450-dependent azo- and flavin reductases. In contrast, 
type II substrates decrease the redox potential of microsomal 
cytochrome P-450 and would be expected to decrease the rate of 
amaranth and flavin reduction.
The possible sites of interaction of amaranth and flavin with 
the components of the NADPH-dependent electron transfer chain are 
presented in Fig. 3.10, The data presented in this chapter suggest 
that amaranth reduction in the absence of supplementary flavin 
(Fig. 3.10a)could occur by pathways 1 or 2, as Lineweaver-Burk plots 
were linear indicating an interaction with a single microsomal 
enzyme, thereby excluding pathway 3. In addition, the carbon monoxide 
sensitivity of this non-supplemented reaction implicates cytochrome 
P-450 (P-450) as the electron donor (pathway 1) rather than the 
flavoprotein NADPH-cytochrome c (P-450) reductase (Fp) (pathway 2).
The changes in activity observed when type I or type II substrates 
are introduced into the system are also consistent with pathway 1 .
Fig. 3.1Q
Possible sites of interaction of components of the NADPH-dependent
electron transfer chain with flavin and/or amaranth
<
,(a) Non-flavin supplanented azoreduction
1 N A D  PH ---------- ► Fp ----- ► P-450 ---------► Dye
2 N A D P H  ----------- ► Fp -------► Dye
3 N A D P H  ----------^Fp ----- ► P - 4 5 0 --------- > Dye
\
Dye
(b) Flavin reduction
4 N A D P H  ---------- ► Fp ----- ► P - 4 5 0 — ------ ► Flavin
5 N A D P H  ------- --- ► Fp --- — ► Flavin
6 N A D P H   ----------► Fp --- — ► P-450 —  -►■Flavin\
Flavin
(c) Flavin supplemented azoreduction
7 N A D P H ----------- ► Fp  ► Flavin --------- >Dye
8 N A D P H  --------► Fp  > P— 450-------- ► Flavin
/
Dye
Microsomal flavin reduction is responsive to the presence of 
carbon monoxide, type I compounds or type II ligands, implicating 
cytochrome P-450 as the electron donor in this reaction (Fig. 3..10b, 
pathway 4), rather than NADPH-cytochrome c (P-450) reductase (path­
way 5). Lineweaver-Burk plots for this activity yield a single 
phase and thereby exclude multiple sites of interaction between 
soluble flavin and the components of the NADPH-dependent electron 
transfer chain (pathway 6).
However, amaranth and flavin appear to interact with cytochrome 
P-450 at separate sites, as illustrated by the differences in the 
type of carbon monoxide inhibition observed with these two classes 
of substrate. Further, different mechanisms of stimulation and 
inhibition are observed when type I or type II compounds are 
introduced into the system, dependent upon the presence or absence 
of flavin in the assay. These findings may explain the biphasic 
nature of the kinetic data obtained from Lineweaver-Burk plots of 
flavin-supplemented azoreductase activity and flavin concentration. 
Such a derivation from linearity may result from:
(i) the interaction of one enzyme with two substrates;
(ii) the interaction of two enzymes with one substrate,
(Alvares and Mannering, 1970; Pederson and Aust, 1970). The possible 
pathways involved in these reactions are presented in Fig. 3 .i0e't 
As already mentioned, in experiments using intact microsomes, no 
interaction between flavin and NADPH-cytochrome £ (P-450) reductase 
was observed (pathways 5 and 6). Therefore pathway 7 does not
operate during flavin supplemented azoreduction. Carbon monoxide 
inhibited both the slow phase and the fast phase of the flavin 
supplemented activity implicating cytochrome P-450 in both of 
these pathways. Further evidence for a haemoprotein mediated
reaction came from the variation of activity which resulted when 
compounds which gave type I or type II binding spectra were introduced 
into the system. The biphasic azoreductase activity . in the 
presence of supplementary flavin may represent the summation of two 
separate activities, comprising pathways 1 and 8 . Thus, at low 
levels of flavin supplementation (nthe slow phase'’), the majority of 
the azoreductase activity observed will be mediated by pathway 1, 
with only a minor transfer of electrons via pathway 8 . Increasing 
the concentration of flavin will increase the flow of electrons 
through the flavin-mediated pathway, while the direct cytochrome 
P-450/amaranth interaction remains intact. However, at very high 
concentrations of soluble flavin ("the fast phase"), amaranth 
reduction will be largely via pathway 8 due to the great excess of 
flavin relative to azo compound. Thus, the activity of the flavin 
supplemented azoreductase will be dependent upon the affinity of 
the different binding sites on cytochrome P-450 for amaranth and 
flavin, and the relative concentration of these two substrates.
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Chapter 4
THE ROLE PLAYED BY COMPONENTS OF THE HEPATIC MICROSCMAL 
NADPH-DEPENDENT ELECTRON TRANSFER CHAIN IN THE REDUCTION 
OF AZO COMPOUNDS in vitro
4,1. ‘ ‘ Introduction
The activity of the microsomal NADPH-dependent electron transfer 
chain may be altered by pretreatment of animals with compounds which 
alter the specific content of cytochrome P-450 and its flavoprotein 
reductase (Fig. 4.1). Manipulations of this nature permit the 
identification of the enzymes responsible for a given metabolic 
pathway if the activity under observation follows the variation in 
a particular enzyme or complex of enzymes. The following compounds 
were administered to male rats:
Cobaltous chloride influences liver haem metabolism and inhibits 
the synthesis of hepatic microsomal cytochrome P-450 (Tephly and 
Hibblen, 1971-; DeMatteis and Unseld, 1976).
2. 2-Allyl-2-isopropylacetamide increases the degradation of haem 
and haemoproteins in the liver and results in the rapid loss of 
cytochrome P-450 (DeMatteis, 1971? DeMatteis and Unseld, 1976).
3. Carbon tetrachloride is metabolised in vivo by a radical mechanism 
with extensive peroxidative damage to the microsomal membrane 
(Burdino et al., 1973; Recknagel et al., 1974), and destruction
of cytochrome P-450 (Smuckler et al., 1967; Glende, 1972).
However, NADPH-cytochrome C (P-450) reductase is largely unaffected 
by this hepatotoxin (Glende, 1972).
4. 3-Methylcholanthrene increases the specific content of hepatic 
microsomal cytochrome P-448 and associated activities (Boobis et al., 1977 
Guepgerich, 1977), with little or no change in NADPH-cytochrome £
(P-450) reductase activity (Hernandez et al., 1967b).
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Fig- 4.1.
The interaction of various agents with the hepatic microsomal 
NADPH-electron transfer chain in vivo and in vitro
N A D P H  — — N A D P H  “ Cytochrome c  ^Cytochrome
(P-450) Reductase P-450
1,2 , 2,3,4,5,6
1 2-Bromo-4 ’ -n it r oac etophenone
2 Phenobarbitone
3 3-Methylcho1anthrene
4 2-Allyl-2-isopropylacetamxde
5 Carbon tetrachloride
6 Cobaltous chloride
5. Phenobarbitone increases the specific content of cytochrome P-450 
in the microsomal fraction, and induces the specific activity of 
NADPH-cytochrome c (P-450) reductase (Hernandez et al., 1967b;
Kuriyama et al., 1969).
In addition,the microsomal fraction was incubated with 2-bromo-4(- 
nitroacetophenone in vitro, an agent which alkylates functional groups 
within the flavoprotein NADPH-cytochrome c (P-450) reductase and 
leads to a considerable decrease in the functionality of this 
enzyme. (HLavica and Kehl, 1977). In contrast, cytochrome
P-450 content is unaffected by this procedure (Hlavica and Kehl, 1977).
The resulting variation in azoreductase activity in the
*
absence and presence of supplementary flavin was examined for any 
correlation with the fluctuations observed in cytochrome P-450 content 
and NADPH-cytochrome £ (P-450) reductase activity.
4.2. Materials
Cobaltous chloride, diethylether, hydrochloric acid, perchloric 
acid, potassium•ferricyanide'. sodium chloride,sodium dithionite, 
sodium hydroxide and sodium nitrite, and "Aristar” grade carbon 
tetrachloride were purchased from BDH Ltd., Poole, Dorset; 
cytochrome c, histidine, 3-methylcholanthrene, trypsin and trypsin 
inhibitor were supplied by the Sigma Chemical Company, Poole, Dorset; 
dimethylaniline, was supplied by the Aldrich Chemical Company 
Gillingham, Kent; 2-bromo-41-nitroacetophenone was purchased from 
Kodak-Eastman, London; phenobarbitone-sodium was supplied
gratis by May and Baker, Dagenham, Essex; 2-aliyl-2-isopropylacetamide 
was a gift from Dr, A.H. Gibbs, M.R.C. Toxicology Unit, Carshalton, 
Surrey,
All other reagents were as previously described.
4.3. Pr etr eatment of animal s
Male Wistar albino rats (180 - 200 g) were used in all studies.
(a) Cobaltous chloride
Animals were injected subcutaneously with cobaltous chloride in 
physiological saline (0.9% sodium chloride, w/v) at 60 mg/kg of body 
weight on two consecutive days. Control animals received an 
equivalent volume of saline. Animals were killed 24 h after receiving 
this second dose, and fasted for the final 20 h prior to sacrifice.
(b) 2-All.yl-2-isopropylacetamide
Rats were fasted overnight for 20 h and treated with a single 
subcutaneous injection of 2-aH.yl-2-isopropylacetamide (AIA) at 
400 mg/kg body weight, given as a 40 mg/nd solution in saline.
Control animals received an equivalent volume of saline. Both 
groups of animals were sacrificed 5 h after treatment.
In a subsequent study, non-fasted animals were injected with 
AIA or saline as described, and fasted for 20 h prior to sacrifice.
(c) Carbon tetrachloride
The experimental group received a single intraperitoneal 
injection of a 1:1 mixture of carbon tetrachloride/com oil at 
3.5 ml/kg body weight 24 h prior to sacrifice. The control 
animals received an equivalent volume of vehicle. Animals were 
fasted for the final 20 h prior to death.
(d) 3-Methylcholanthrene
Animals received three successive daily intraperitoneal injections 
of 3-methylcholanthrene in com;oil (5 mg/ml) at 25 mg/% body 
weight. Control animals received an•equivalent amount of com oil.
The animals were sacrificed 24 h after the final treatment, after 
fasting for the final 20 h prior to death.
(e) Phenobarbitone
Experimental animals were treated with intraperitoneal injections 
of phenobarbitone sodium in saline at 80 mg/kg body weight for three 
consecutive days. Control animals received an equal volume of 
saline. Animals were killed 24 h after receiving the last 
injection, and were fasted for 20 h prior to sacrifice.
4.4. Isolation of hepatic microsomal fraction
Animals were sacrificed by cervical dislocation and the hepatic 
microsomal fraction isolated as described in 2.4. The microsomal 
protein concentration present in the stock microsomal suspension 
was estimated as described in 2.5.
4.5. Treatment of microsomal fraction with 2-bronio-4'-nitroacetophenone
The washed microsomal fraction was diluted to approximately 
2 mg microsomal protein/ml with 50 mM sodium phosphate buffer, 
pH 7.4, containing 1 mM EDTA. Aliquots of 20 ml were incubated 
with 2-bromo-41 -nitroacetophenone (25 - 400 yM) at 37° for 10 min 
in a shaking water bath (60 cycles/min) (Hlavica and Kehl, 1977). 
Alkylation was stopped by the addition of a freshly prepared 
solution of histidine (final concentration 20 mM) and the 
microsomal fraction sedimented at 256,000 g^y for 20 min in the 
60 Ti rotor of a Beckman L5-65 Ultracentrifuge. The resulting 
microsomal pellet was resuspended twice in ice-cold 50 mM sodium 
phosphate buffer, pH 7.4, containing ‘0.15M potassium chloride and 
resedimented as before. Control incubations were treated in a 
similar manner in the absence of 2-bromo-4l -nitroacetophenone.
4.6. Estimation of hepatic microsomal azoreductase activity
Azoreductase activity was determined as described previously, 
in the absence or presence of 300 yM FMN (2.6 and 2.8 respectively). 
The inhibitory effect of carbon monoxide on the non-flavin 
supplemented activity was investigated as described in 3.4 . In 
experiments utilising microsomes from phenobarbitone or 
3-methylcholanthrene pretreated rats, a final protein concentration 
of about 0.5 mg/ml was employed because of the increased activity 
of the microsomal enzymes.
4.7. Estimation of cytochrome P-450 content
Microsomal cytochrome P-450 content was determined by the 
method of Cmura and Sato (1964a). A sample of the stock 
microsomal suspension was diluted to a protein concentration of 
about 1.5 mg/ml with 50 mM sodium phosphate buffer, pH 7.4, 
and reduced with a few milligrams of sodium dithionite. The 
reduced sample was divided between two matched 1 cm pathlength 
glass spectrophotometer cells, and the absorbance baseline 
recorded between 390 and 500 m  on a Pye-Unicam SP1800 
spectrophotometer. Carbon monoxide was then bubbled carefully 
through the contents of the sample cuvette and the resulting 
difference spectrum recorded. The concentration of cytochrome P-450 
was calculated from this dithionite-reduced carbon monoxide difference 
spectrum using an extinction coefficient between 450 and 490 nm 
of 91 litre.mmol-^.cm-'*' (Omura and Sato, 1964b).
4.8. Estimation of cytochrome b^ content
The microsomal fraction was diluted to about 1.5 mg/ml with 50 mM
sodium phosphate buffer, pH 7.4, and the baseline recorded between
390 and 450 nm on a Pye-Unicam SP1800 spectrophotometer. NADH
(0.45 mM) was introduced into the sample cuvette, and the
resulting difference spectrum recorded. An extinction increment
-1 -1between 409 and 424 nm of 185 litre.mmol .cm was employed to 
calculate the concentration of cytochrome b^ (Hrycay and Plough, 1974).
4.9. Estimation of NADPH-cytochrome c(P-450) reductase activity
NADPH-cytochrome £ reductase activity was determined by
following the rate of reduction of ferricytochrome £ at 550 nm.
The sample and reference cuvettes contained cytochrome £ (50 yM)
and microsomal protein (about 70 yg/ml) in 3.0 ml of 50 mM
sodium phosphate buffer, pH 7.4. The reaction was initiated by
the introduction of NADPH (0.15 mM) into the sample cell, the
reference receiving an equal volume of buffer. A millimolar
-1 -1extinction coefficient of 21 litre.mmol .cm was used to 
estimate the generation of ferrocytochrome £ at 550 nm 
(Williams and Kamin, 1962).
4.10. Estimation of NADH-cytochrome b^ (ferricyanide) reductase activity
The activity of this NADH-dependent flavoprotein was assayed employing
potassium ferricyanide as an artificial electron acceptor. The sample
and reference cells con tained Herr icyanide(l mM) and microsomal
protein (about 100 yg/ml) in 3 ml of 50 mM sodium phosphate buffer,
pH 7.4. The reaction was initiated by the introduction of NADH
(0.15 mM) into the sample cuvette, the reference cell receiving an
equal volume of buffer. A millimolar extinction coefficient of 
-1 -1
1.02 litre.mmol .cm was used to estimate the reduction of 
potassium ferricyanide, as indicated by the decrease in absorbance 
at 420 nm (Hrycay and Prough, 1974).
4.11. Estimation of mixed function amine oxidase activity
The microsomal fraction from male Wistar albino rats (180 - 200 g) 
was isolated by differential centrifugation as described in 2.4, 
after initial homogenisation in 50 mM tricine buffer, pH 7.4, 
containing 0.25 M sucrose.
, Mixed function amine oxidase activity was estimated by 
modifications to the method of Ziegler and Pettit (1964), as 
suggested by Dr. D. Ziegler (personal communication).
The reaction system contained approximately 1 mg/ml microsomal 
protein, a NADPH-generating system (0.5 mM NADP+, 6 mM glucose 
6-phosphate and 1 U/ml glucose 6-phosphate dehydrogenase) and 
3 mM dimethylaniline hydrochloride in a final volume of 9.0 ml 
tricine buffer, pH 8.4. (Dimethylaniline hydrochloride was freshly' 
prepared by dissolving dimethylaniline in 50 mM HC1 and adding 
concentrated HC1 until the pH of the solution was between 2-3.) The 
microsomal fraction and NADPH-generating system were preincubated 
together for 5 mil at 37°, and the reaction was initiated by the 
addition of warmed substrate. The assay was performed in 25 ml 
conical flasks, open to the atmosphere, in a shaking water bath 
(37°; 60 cycles/min) for 10 min. "Blank” incubations were devoid
of substrate.
The reaction was terminated by the addition of 1.5 ml of 
perchloric acid (final concentration 0.3 M) and the flasks stood on 
ice for 5 min. Dimethylaniline hydrochloride was added to the
appropriate flasks for the "blank” incubations. The precipitated
protein was removed by centrifugation at 2,000 rpm for 10 min
in the large swing-out rotor of a Mistral 6h centrifuge. Triplicate
aliquots of 3 ml of this deproteinised supernatant were adjusted to
pH 9.4 with 0.5 ml of 2.1 M sodium hydroxide, and 0.5 ml of 2.4 M
glycine-sodium hydroxide buffer, pH 9.4. Each sample was then
extracted twice with 8 ml of diethyl ether, discarding the organic
solvent fraction which contained residual substrate. After the final
extraction, the aqueous phase was warmed in a water bath at 60° for
5 min followed by Vortex-mixing for 10 s to release any trapped
ether. A 3 ml aliquot was adjusted to pH 2.5 with 0.5 ml of 1.6 M
trichloroacetic acid, followed by nitrosation with 0.1 ml of
aqueous sodium nitrite (final concentration 9 mM). Samples were
then incubated at 60° for 7 min to allow colour development. The
yellow £-nitroso derivative of dimethylaniline was determined
spectrophotometrically at 420 nm on a Cecil 272 spectrophotometer '
after allowiig the samples to cool to room temperature. A
-1 -1millimolar extinction coefficient of 8.2 litre.mmol .cm was used 
to estimate the amount of product present (Ziegler and Pettit, 1964).
4.12. Statistical analysis of results.
Statistical significance between the results from control and 
test groups after these various treatments ,.was: estimated on an 
Olivetti P652 desk top computer, using T-test programme ST0706.
4.13. RESULTS
The pretreatment of rats with cobaltous chloride resulted in 
highly significant decreases in the concentration of hepatic 
microsomal cytochrome P-450 and cytochrome b,- (Table 4.1). In 
contrast, the flavoproteins NADH-cytochrome b^ (ferricyanide) 
reductase, NADPH-cytochrome £ (P-450) reductase and the mixed 
function amine oxidase were more resistant to this compound and 
showed less alteration in activities (Table 4.1). Non-flavin 
supplemented azoreductase activity was decreased by this treatment 
(40 - 50%) to a similar degree to the 30 - 60% fall observed in 
cytochrome P-450 content (Table 4.2f Table 4.3). Flavin 
supplemented azoreductase activity was also decreased by this 
pretreatment (Table 4.2; Table 4 .3),as-were the carbon monoxide- 
sensitive and -insensitive pathways of the non-flavin supplemented 
azoreductase (Table 4.3). The decrease in the carbon monoxide 
sensitivity of this reaction (60%) is of a similar order to the 
cobaltous chloride-induced destruction of cytochrome P-450 (Table 4.3).
Carbon tetrachloride pretreatment greatly reduced the cytochrome 
P-450 content of the hepatic microsomal fraction, with smaller 
decreases in cytochrome b<- content and the activity of the flavo­
proteins NADH-cytochrome b^ (ferricyanide) reductase and NADPH- 
cytochrome^ (P-450) reductase, (Table 4.4; Table 4.5). In 
contrast, the activity of the NADPH-dependent amine-oxidase 
remained essentially unchanged (Table 4.5). The activities of the 
non-flavin supplemented and flavin-supplemented azoreductase
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also decreased, and paralleled the variation in cytochrome P-450 
content more closely than the change in NADPH-cytochrome c (P-450) 
reductase activity (Iable4.6). Carbon tetrachloride pretreatment 
diminished the sensitivity of the non-flavin supplemented 
azoreductase activity to carbon monoxide (the CO-sensitive 
path-way) and decreased the residual carbon monoxide insensitive 
activity (Table 4.7).
The administration of 2-allyl-2-isopropylacetamide (AIA) to 
rats resulted in a time-dependent change in cytochrome P-450 
content, with an elevation in activity of the flavoprotein 
NADPH-cytochrome £ (P-450) reductase at the times studied ,
(Table 4.8). Thus, 5 h after treatment, the cytochrome P-450 
content of the microsomal fraction was significantly decreased, 
but returned to control levels 20 h after treatment. In 
comparison, NADPH-cytochrome c (P-450) reductase activity 
exhibited a sustained increase in activity at both of these 
time intervals. The activity of the azoreductase, both in the 
absence or presence of supplementary FMN, followed the variation 
in P-450 haemoprotein content rather than the elevation in NADPH- 
cytochrome c (P-450) reductase activity (Table 4.8).
Phenobarbitone pretreatment resulted in a highly significant 
increase in the cytochrome P-450 content of the hepatic microsomal 
fraction, coupled with a marked increase in the activity of 
NADPH-cytochrome c (P-450) reductase (Tables 4.9 and 4.10). The 
activity of the mixed function amine oxidase remained unchanged
114
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after this regime (Table 4.10). The inductive effect of pheno- 
barbitone was also observed as an increase in azoreductase 
activity (Tables 4.9 and 4.10). However, while the non-flavin 
supplemented azoreductase activity was significantly increased, 
the flavin supplemented activity was less responsive. Microsomal 
azoreduction in the test group showed a greater sensitivity to 
carbon monoxide inhibition than controls, while the carbon 
monoxide-insensitive pathway was less activ e after pheno- 
barbitone pretreatment (Table 4.10).
Pretreatment of male rats with 3-methylcholanthrene for three 
days resulted in a highly significant induction of hepatic 
microsomal cytochrome P-448, with a slight decrease in NADPH- 
cytochrome c (P-450) reductase activity (Table 4.11). This 
inductive effect was reflected by an increase in the total non­
flavin supplemented azoreductase activity. In the absence of 
supplementary flavin, dye reduction showed an increased sensitivity 
to inhibition by carbon monoxide after 3-methylcholanthrene 
pretreatment, while the carbon monoxide insensitive azoreductase 
activity remained unchanged. The activity of the flavin- 
supplemented azoreductase remained essentially the same as that 
present in the control group (Table 4.11).
Incubation of the microsomal fraction with 2-bromo-41 -nitro- 
acetophenone resulted in a concentration dependent inactivation of 
NADPH-cytochrome £ (P-450) reductase and NADH-cytochrome b^
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(ferricyanide) reductase activities (Fig, 4,2). In contrast, the 
haemoproteins cytochrome P-450 and cytochrome showed a more 
resistant response to this alkylating agent, with cytochrome b^ 
the most resistant of the two. Non-flavin supplemented azo­
reductase activity was also decreased by this agent, but by an 
amount that was intermediate between the observed decreases in 
cytochrome P-450 content and NADPH-cytochrome c (P-450) reductase 
activity. Flavin supplemented azoreductase activity closely 
paralleled the fall in the functionality of the NADPH-dependent 
flavoprotein,
4.14. DISCUSSION
The in vivo administration of cobaltous chloride, carbon 
tetrachloride and allylisopropylacetamide resulted in a decreased 
hepatic microsomal cytochrome P-450 (P-450) content, witn variable, 
effects on NADPH-cytochrome c (P-450) reductase (Fp) activity, 
cytochrome b^ content, NADH-cytochrome b^ (ferricyanide) reductase 
activity and the NADPH-dependent mixed function amine oxidase. 
Under these different treatment regimes, the activity of the 
non-flavin supplemented azoreductase appeared to be related to 
the observed fluctuations in hepatic microsomal cytochrome P-450 
content (Tig, 4.3., pathway 1), In addition'^  treatments that 
decreased cytochrome P-450 content resulted in a, decreased 
sensitivity of the non-flavin supplemented azoreductase activity 
to carbon monoxide inhibition. The flavin supplemented azo­
reductase activity also exhibited a downward trend after the
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Fig. 4.5,
Possible sites of interaction between components of the
NADPH-dependent electron transfer chain and amaranth and flavin
N A D P H  -> Fp -----------> P-450 ---- — — > D ye
N A D P H  --------- > Fp — ^ - > R-450
Flavin >
3 NAD PH F p ------------- ► P—4 5 0 >  Flavin
administration of these compounds in vivo, but. in these cases 
the variation in BIN-mediated amaranth reduction did not always 
correlate with the depression in haemoprotein content. This 
suggests the involvement of another enzyme in the flavin- 
supplemented azoreductase activity. This may reflect the 
uncoupling of electron transfer from NAJDPHrcytochrome\C Q M  50), 
reductase to cytochrome Pr450 when the microsomal content; of 
this haemoprotein is decreased relative to the fiavoprotein'.
This may facilitate electron.transfer from NADPH-cytochrome c 
(P-450) reductase to soluble flavin allowing this fiavoprotein 
to function in this electron transfer to amaranth 
(Fig, 4.3., pathway 2). This interaction would be comparable to 
the ’’carbon monoxide insensitive’’ azoreductase activity reported 
for NADPH-cytochrome c QM50) reductase when neopronfosil is 
substrate (Hernandez-enal., 1967a, b),
Phenobarbitone and 3 rnjethy 1 qho 1 ant hi1 ene pretreptmenb resulted 
in increases in the content of cytochrome Pr-450^type haemoprotein 
present in the hepatic microsomal fraction, Phenobarbitone also 
increased the specific activity of NADPH-cytochrome c (P-450) 
reductase. Under these conditions, the increased activity of the 
non-flavin supplemented azoreductase activity can be attributed 
to increases in cytochromes P-450 and P-448, Thus, a greater 
amount of haemoprotein was available for interaction with 
amaranth, resulting in a net increase in azoreductase activity 
(Fig, 4.3., pathway 1). In addition, the increased fiavoprotein 
activity observed after phenobarbitone induction may facilitate
electron transfer to cytochrome P-450 and further enhance the 
rate of amaranth reduction. However, in these experiments no 
evidence was obtained for a direct interaction between fiavo­
protein and amaranth. This may indicate tight coupling between 
NADPH-cytochrome c (P-450) reductase and cytochrome P-450 
nfter induction by phenobarbitone and 3-methycholanthrene.
However, the ’’carbon monoxide sensitive*1’ azoreductase activity 
is increased after these pretreatments and again indicates 
the increased involvement of cytochrome P-450/P-448 in the non­
flavin supplemented activity.
Flavin supplemented azoreductase activity was induced to 
a much smaller extent after phenobarbitone and 3-methylcholanthrene 
pretreatment. Indeed, the activity present in both of these 
fQSt groups failed to differ significantly from the appropriate 
control result. This may indicate that electron transfer from 
NADPH-cytochrome £ (P-450) reductase to cytochrome P-450/P-448 
has become rate limiting due to the large increase in haemoprotein 
content relative to the activity of the fiavoprotein.
The rate of cytochrome P-450 reduction can be made rate 
limiting in control microsomes by incubation of the microsomal 
fraction with 2-bromo-4 '-nitroacetophenone. This alkylating 
agent destroys the electron transferring properties of the 
flavoproteins NADPH-cytochrome £ (P-450) reductase and NADH- 
cytochrome b^ (ferricyanide) reductase, with^minor effects on 
cytochromes bj- and P-450. The NADPH-dependent reduction of
amaranth, in both the absence and presence of supplementary 
flavin, followed the decreased functionality of NADPH- 
cytochrome c (P-450) reductase, indicating that in pathways 
1 and 3 (Fig, 4,3), electron transfer to cytochrome P-450 
had become rate limiting.
In summary, both the non-flavin supplemented and flavin 
supplemented azoreductase activities require the presence of both 
components of the hepatic microsomal NADPH-dependent electron 
transfer chain for the efficient reduction of azodyes, A 
decrease in cytochrome P^450 content results in a proportional 
loss of non-flavin supplemented azoreductase activity, while 
induction of this haemoprotein increases the rate of dye 
reduction. Certain treatments may lead to uncoupling of 
electron transfer from NADPH-cytochrome £ (Pr-450) reductase to 
cytochrome P-450. Under these conditions, flavin-supplemented 
azoreductase activity may be due to an interaction between 
this fiavoprotein and soluble flavin. In addition, electron 
transfer to cytochrome P-450 may become rate limiting during the 
flavin-supplemented reduction of amaranth, especially after 
induction of this class of haemoprotein with phenobarbitone or 
3-methylcholanthrene.
Chapter 5
‘ SOLUBILISATION, PURIFICATION AND RECONSTITUTION
OF HEPATIC MICROSCMAL AZOREDUCTASE ACTIVITY
5.1. Introduct ion
In recent years, many laboratories have directed their attention 
toward the purification of hepatic microsomal enzymes, with the 
ultimate goal of reconstituting a variety of oxidative cytochrome 
P-450 functions (Lu et al 1971, 1974; Yang and Strickhart, 1975; 
French and Coon, 1979). However, no previous attempt has been made 
to purify and reconstitute the enzymes responsible for the hepatic 
microsomal reduction of flavins and azo compounds.
Studies utilising intact microsomes and a variety of inhibitors 
have led to the postulate that two major routes of azoreduction 
exist. These consist of a carbon monoxide sensitive cytochrome P-450 
(Hernandez et al., 1967a, b; Fujita and Peisach, 1978a) or 
cytochrome P-448 (Fujita and Peisach, 1978a) pathway, and a carbon 
monoxide insensitive pathway attributed to the fiavoprotein, NADPH- • 
cytochrome £ (P-450) reductase (Mueller and Miller, 1950; Hernandez 
et al., 1967a, b). In addition, a novel reductive route, separate 
from haemoprotein or fiavoprotein, was reportedly induced by 
3-methylcholanthrene (Hernandez et al., 1967b). Cytochrome bj- 
has also been suggested as an electron carrier during azo dye 
reduction (Fujita and Peisach, 1977 b).
Reconstitution of azoreductase activity from purified components 
of the hepatic microsomal NADPH-dependent electron transfer chain 
may indicate the relative importance of these enzymes in the intact 
microsomal azoreductase.
5.2. Materials
Acetic acid, acrylamide, Amberlite XAD-2, ammonium persulphate, 
bis-acrylamide, bromophenol blue, Coomassie blue, isopropanol, 
mercaptoethanol, sodium cholate and sodium dodecyl sulphate were 
purchased from BDH, Poole, Dorset; "Analar” grade glycerol and 
chloroform were supplied by the same company; 2’-AMP, dilauroyl- 
phosphatidylcholine, polyethylene glycol 6000 > trypsin, trypsin inhibitor 
and Tris-base were supplied by the Sigma Chemical Co., Poole, Dorset;
dithiothreitol and N,N,N! ,N’ ,-tetramethylethylenediamine were 
purchased from the Aldrich Chemical Company, Gillingham, Kent; 
molecular weight markers (aldolase, bovine serum albumin, catalase, 
chymotrypsinogen A, and hen egg albumin) were supplied by the 
Boehringer Corporation, Lewes, Sussex; DEAE-cellulose (DE 52) 
was purhcased from Whatman Ltd., Maidstone, Kent, and 2',51 -ADP- 
Sepharose 4B from Pharmacia Ltd., Hounslow, Middlesex; Renex 690 
was supplied gratis by Honeywill-Atlas Ltd., Carshalton, Surrey.
All other reagents were as described previously.
5.3. Trypsin digestion of the hepatic microsomal fraction
The washed microsomal fraction was resuspended in 50 mM sodium 
phosphate buffer, pH 7.4, containing 25% (v/v) glycerol and 1 mM 
EDTA, to a protein concentration of approximately 20 mg/ml. The 
suspension was flushed with nitrogen, and digested at 1° for 22 h
with 25 yg trypsin/mg microsomal protein in a screw-capped actinic • 
glass container. Digestion was terminated by addition of a two-fold 
excess of trypsin inhibitor. A control sample was stored under 
similar conditions without the addition of trypsin/trypsin inhibitor. 
The digested material was centrifuged at 231,600 g^  for 25 min. The 
sedimented and supernatant fractions were diluted with 50 mM 
sodium phosphate buffer, pH 7.4, containing 1 mM EDTA to a protein 
concentration of approximately 3.5 mg/ml. Cytochrome P-450, NADPH- 
cytochrome c (P-450) reductase, cytochrome b^, NADH-cytochrome b<- 
(ferricyanide) reductase and non-flavin supplemented and flavin 
supplemented azoreductase activities were determined as described 
in Chapter 4 on the control, digested pellet and solubilised 
supernatant fractions.
5.4. Preparation of DEAE-cellulose
Whatman DEAE-cellulose (DE52, 150 g) was dispersed in 3 1 of the 
appropriate column running buffer (5.5, 5.6) and stirred gently for 
5 min in the cold room. The resulting suspension was titrated with 
the acid component of the buffer to give the correct pH at 8°. The 
supernatant fraction was separated from the cellulose by filtration 
through a coarse sinter and the ion-exchange material again dispersed 
in 1.5 1 of the above buffer. This cycle of filtration and 
resuspension was repeated with a further 2 x 1.5 1 of buffer. After 
the final resuspension, the sluny was allowed to settle in a 2 1 
measuring cylinder for 60 min, after which the supernatant liquour 
containing the fines was aspirated off.
The equilibrated DEAE-cellulose was dispersed in 300 ml of the' 
appropriate running buffer and the column packed to the desired 
dimensions and kept in the cold room. The flow rate was maintained 
at 100 ml/h with a Wat son-Mar low {flow inducer, model MHRE7, at 
the outlet of the column. The packed column was washed with 500 ml 
of this same buffer prior to use.
5.5. Preparation of 215T-ADP-Sepharose 4B
2 ’ 51-ADP-Sepharose 4B (5 g) was stirred gently for 3 h in the 
cold room with 500 ml of 0.1 M sodium phosphate, pH 7.0 at 8°.
The excess liquor was removed by filtration through a course sintered 
funnel, and then washed with 1 1 of this same cold buffer. The 
resin was then dispersed in 100 ml of 10 mM sodium phosphate buffer, 
pH 7.7 at 8°, containing 20% (v/v) glycerol, 0.5 mM EDTA, 0.2 mM 
dithiothreitol (DTT), 0.1% (v/v) Renex 690 and 2 yM FMN, and poured 
into a 1.5 x 15 cm glass column. This bed volume of approximately 
20 ml was washed with 300 ml of the above running buffer at a gravity 
induced flow rate of 170 ml/h.
5.6. Purification of NADPH-cytochrome c (P-450) reductase.
The fiavoprotein, NADPH-cytochrome c (P-450) reductase was 
purified as described by Yasukochi and Masters (1976).
Male Wistar Albino rats (approximately 200 g) were pretreated
with, phenobarbitone sodium as described in 4.3, and the hepatic 
microsomal fraction isolated as described in 2.4 after homogenisation 
in 0.1 M Tris-BCl buffer, pH 7.7, containing 0.15 M KC1 and 1 mM 
EDTA. The washed microsomal fraction was resuspended in 0.10 M Tris- 
HC1 buffer, pH 7.7 at 8°, containing 20% (v/v) glycerol, 0.5 mM EDTA 
and 0.2 mM DTT to a protein concentration of about 30 mg/ml and 
stored under nitrogen at -40°.
All subsequent operations were performed in the cold-room (8°) 
and protected from light. The pH of all the buffers used in this 
study were adjusted to give the desired value at 8°.
The thawed microsomal suspension (2^80 g protein in 90 ml) 
was mixed with 44 ml of 10% (v/v) Renex 690 and 303 ml of 0.1, M 
Tris-HCl buffer, pH 7.7, containing 20% (v/v) glycerol, 0.2 mM EDTA,
0.2 mM DTT, 0.1% (v/v) Renex 690 and 2 yM FMN (buffer A). This 
mixture (1% (v/v) detergent; 6.5 mg microsomal protein/ml) was stirred 
in the cold room for 20 min. The resulting reddish solution was 
centrifuged at 77,000 g^y in the 8 x 50 ml rotor of an MSE Super 
Speed 50 centrifuge cooled to 4°, for 40 min. The clear supernatant 
fraction was collected and gravity fed at 25 ml/h onto a DEAE-cellulose 
column (3 x 30 cm) previously equilibrated with buffer A. The 
column was then washed with 500 ml buffer A containing 50 mM KC1 
at 100 ml/h. The flow rate was maintained by a Watson-Marlow 
flow inducer, model MHRE7. NADPH-cytochrome c (P-450) reductase 
activity was eluted (25 ml/h) with a linear concentration gradient 
of 0.05 - 1.5CM KC1 in buffer A. Fractions of approximately 10 ml 
were collected using an LKB Ultrorac II fraction collector. The
eluent was assayed for NADPH-cytochrome c (P-450) reductase activity 
as described in 4.9 and samples containing activities in excess of 
0.75 ymol cytochrome c reduced/min/ml pooled. This bulked material 
was dialysed against 4 1 of 10 mM sodium phosphate, pH 7.7, 
containing 20% (v/v) glycerol, 0.2 mM EDTA, 0.2 mM DTT*' 0.1% (v/v)
Renex 690 and 2 yM FMN (buffer B).
The semi-purified, dialysed fiavoprotein solution was fed onto 
a 2*,5,-ADP Sepharose 4B column (1.5 x 11 cm), previously equilibrated 
with buffer B. The loaded column was washed with 100 ml of buffer B 
at a flow rate of 170 ml/h, followed by 150 ml of 0.20 M sodium 
phosphate, pH 7.7, containing 20% (v/v) glycerol, 0.2 mM EDTA, 0.2 mM 
DTT, 0.1% (v/v) Renex 690, and .2 yM FMN' (buffer c). After re-equilibration 
of the column with 50 ml of buffer B, NADPH-cytochrome £ (P-450) 
reductase activity was eluted batchwise with 1 mM 2’-AMP in buffer B 
(170 ml/h). Fractions of 5 ml were collected and samples with 
NADPH-cytochrome £ (P-450) reductase activities equal to or greater 
than 2 ymol cytochrome £ r educ ed/m in/ml were pooled and dialysed for 
24 h against 4 1 buffer B. After dialysis, 1 ml aliquots were stored 
under nitrogen at -40°.
In order to compare the activity of the purified fiavoprotein 
with the values obtained by other workers, NADPH-cytochrome £ (P-450) 
reductase activity was determined at 30° in 0.30 M potassium phosphate 
buffer, pH 7.7, containing 0.1 mM EDTA. The concentrations of 
NADPH and cytochrome £ were 0.1 mM and 40 yM respectively.
5.7. Purification of cytochrome P-450
The purification of cytochrome P-450 was performed by the method 
of West et al. (1979).
Male Wistar albino rats (approximately 200 g) were pretreated 
with phenobarbitone sodium as described in 4.3, and the hepatic 
microsomal fraction isolated as described in 2.4 after homogenisation 
in 0.15 M KC1. The resulting microsomal pellet was resuspended 
in 0.15 M KC1 containing 10 mM EDTA and resedimented. This washed 
microsomal fraction was stored at -40° under nitrogen at a protein 
concentration of 30 mg/ml,in 0.25 M sucrose.
All subsequent steps were performed in the cold room (8°) and 
protected from light. The pH of all the buffers used in this study 
were adjusted to give the desired value at 8°.
A suspension of 3.5 g microsomal protein in 115 ml of 0.25 M 
sucrose was diluted with 343 ml of 0.10 M sodium phosphate buffer, 
pH 7.4, containing 30% (v/v) glycerol and 1 mM EDTA, and 42 ml of 
25% (w/v) sodium cholate to give a final protein concentration of 
7 mg/ml and a detergent concentration of 2% (w/v). The mixture was 
stirred for 10 min and then 125 ml of a 50% (w/v) solution of 
polyethylene glycol 6000 was added to a final concentration of 
10% (w/v). The mixture was stirred for 10 min and then centrifuged 
for 68 min at 23,000 g^y in the 6 x 250 ml rotor of a MSE High Speed
18 centrifuge, cooled to 4°. The resulting supernatant fraction 
(590 ml) was adjusted to 161 (w/v) saturation by the addition of a 
further 80 ml of 50% (w/v) polyethylene glycol 6000. The mixture 
was stirred for 10 min and centrifuged at 105,000 g^ y. for 1 h in 
the 8 x 25 ml rotor of a MSE Super Speed 50 centrifuge. The 
sedimented material (10 - 16% polyethylene glycol fraction) was 
resuspended by homogenisation in 70 ml of 10 mM sodium phosphate 
buffer, pH 7.4, containing 20% (v/v) glycerol, 0.1 mM EDTA,
0.5% (w/v) sodium cholate and 0.2% (v/v) Renex 690 (buffer D).
This mixture was stirred for 30 min and applied to a DEAE-cellulose 
column (2.5 x 50 cm) previously equilibrated with buffer D. The 
column was washed with buffer D containing 25 mM KC1, using a 
Watson-Marlow flow inducer, model MHRE7, at the outlet of the 
column to maintain a flow rate of 100 ml/h. After approximately 
600 ml of wash buffer had been pumped through the column, a red 
band about 3 cm wide concentrated midway down the column. The resin 
above the band was carefully rdmoved and the coloured cellulose taken 
into suspension by agitating the material with a glass rod after the 
addition of 30 ml of wash buffer. This slurry was applied to a second 
Whatman DE52 column (2.5 x 45 cm) previously equilibrated with buffer D. 
Cytochrome P-450 was eluted at 50 ml/h overnight with a linear gradient 
consisting of 500 ml of buffer D containing 25 mM KC1 and 500 ml of 
buffer D containing 100 mM KC1. Fractions were collected every 5 ml 
using an LKB UltroThc II. Those fractions having an absorbance at 
417 nm equal to or greater than 0.5 were combined (total volume 70 ml). 
Excess was removed by two treatments with Amberlite XAD-2
beads (8g, then 4 g). The mixture m s  agitated for 1 h at 8° 
on a rotary mixer, and the beads removed by filtration through nylon 
mesh. The cytochrome P-450 eluant was then concentrated to 
approximately 30 nmol/ml by ultrafiltration over an Amicon PM30 
membrane and stored at -40° under nitrogen.
5.8. Estimation of protein content in the presence of detergents.
Protein estimations were performed by the method of Lowry et al., 
(1951) as modified by Dulley and Grieve (1975) for solutions containing 
interfering detergents. Samples and protein standards were diluted 
with 0.5 M sodium hydroxide containing 5% (w/v) sodium dodecylsulphate 
and the protein content determined as described in 2.5.
5.9. Polyacrylamide gel electrophoresis of enzyme samples
Polyacrylamide gel electrophoresis in the presence of 0.1% (w/v) 
sodium dodecyl sulphate (SDS) was performed as described by Laemmli 
(1970). An upper stacking gel containing 3% (w/v) acrylamide
(dimensions 15 x 140 x 1.5 mm) and a lower running gel containing 
10% acrylamide (dimensions 80 x 140 x 1.5 mm) were used.
The running gel was prepared by mixing 10 ml of lower gel buffer 
(1.5M Tris-HCl buffer, pH 8 .8 , containing 0.4% (w/v) SDS)} 13.4 ml 
of aqueous acrylamide stock solution (30% (w/v) acrylamide; 0.8%
(w/v) bis-acrylamide); 0.24 ml of fresh 10% (w/v) ammonium 
persulphate; 20 yl of N,N,N’ jN’-tetramethylethylenediamine 
(TEMHD) and 16.6 ml of distilled water. The glass gel
cassette, sealed with molten 1.5% (w/v) agar and clamped together . 
with four large bulldog clips was positioned vertically, and the 
lower gel poured between the plates to a height of 8 'em. The 
surface was overlayed with water and the gel allowed to set. The 
stacking gel was prepared by mixing 2.5 ml of upper gel buffer 
(0.5 M Tris-HCl buffer pH 6 .8, containing 0.4% (w/v) SDS); 1.0 ml 
of acrylamide stock solution; 60 yl of fresh 10% (w/v) ammonium 
persulphate; 20 yl of TEMED and 6.5 ml of distilled water. The 
water overlay was removed from the surface of the running gel with 
a syringe tipped with a piece of fine diameter plastic tubing and 
the stacking gel added with a pasteur pipette. A perspex comb was 
then introduced into the still fluid stacking gel to form the sample 
wells 3 mm apart. The gel was left to s'et.
Enzyme samples were diluted to about 100 yg protein/ml with 
sample buffer (62.5 mM Tris-HCl buffer, pH 6.8, containing 15% (v/v) 
glycerol, 5% (v/v) mercaptoethanoi, 2.3% (w/v) SDS and 0.001% (w/v) 
bromophenol blue) and heated on a boiling water bath for 4 min. 
Samples of approximately 0.5 -2.0 yg of the purified enzymes and 
10 - 15 yg of solubilised microsomal fraction wrere introduced into 
the stacking gel wells. The following standards were run in 
parallel for comparative molecular weight estimation:
Molecular weight Subunit weight
Chymotrypslnogen A 
Aldolase
Albumin (hen egg)
Catalase
Albumin (bovine serum)
The standards (1 mg each) were mixed together and dissolved in 1 ml 
of sample buffer, followed by heating at 100° for 4 min. A sample 
(10 yl) of this mixture was introduced into the wells in the 
stacking gel.
The gel was electrophoresed from top to bottom at room temperature, 
at a current of 17 mA in the stacking gel and 30 mA in the running gel 
using a Heathkit regulated HV power supply, Model IP 17. The
electrode buffer was 0.192 M glycine/0.025 M Tris adjusted to pH 8.3
with concentrated hydrochloric acid and containing 0.11 (w/v) SDS.
The current was disconnected when the bromophenol blue tracking dye 
was within 0.5 cm of the lower edge of the gel.
Protein bands were fixed and stained with a mixture of acetic 
acid : isopropanol : water (10 : 25 : 65 by volume) containing 
0.051 (w/v) Goomassie blue in the same medium. After standing for 
18 h the gel was destained with a 10 : 10 : 80 (by volume) mixture
of the same solvents until the required degree of contrast was
obtained. Gels were stored in 3$ (v/v) glycerol/distilled water at
25,000 25,000
158,000 39,000
45,000 45,000
240,000 60,000
68,000 68,000
Minimum molecular weight values of the microsomal and purified 
samples were estimated by comparison with protein standards of known 
mobility and molecular weight. Electrophoretic mobility was 
calculated from:
. Distance migrated by protein standard 
Distance migrated by tracking dye
and plotted on the ordinate versus log subunit weight on the 
abscissa.
5.10. Assay methods
Cytochrome P-450 and cytochrome b^ content was determined as 
described in 4.7 and 4.8 respectively. NADPH-cytochrome £ (P-450) 
reductase activity and NADH-cytochrome bj- (ferricyanide) reductase 
activity were determined as described in 4.9 and 4.10 respectively.
5.11. Spectral properties of purified cytochrome P-450 and purified 
NADPH-cytochrome c (P-450) reductase.
The dithionite reduced carbon monoxide difference spectrum of 
purified cytochrome P-450 was obtained as described in 4.7. A protein 
concentration of 70 yg/ml was employed.
The absolute spectrum of the oxidised purified fiavoprotein 
reductase was recorded from 350 - 650 nm on a Varian Cary 219 
spectrophotometer employing automatic baseline correction. One
centimeter pathlength quartz micro-cells were used, with a capacity 
of 0.7 ml. The sample cuvette contained the fiavoprotein at 
approximately 200 yg/ml in 10 mM sodium phosphate buffer, pH 7.7, 
containing 20% (v/v) glycerol, 0.1 mM EDTA, 0.2 mM DTT, 0.11 (v/v)
Renex 690 and 2 yM FMN; the reference cell contained this buffer alone.
5.12. Determination of NADPH-dependent azoreductase and flavin 
reductase activities of purified NADPH-cytochrome c (P-450) reductase
The anaerobic reduction of amaranth (50 - 500 yM) in the absence or 
presence of supplsnentary flavin was determined as described in 2.6 and 
2.8 respectively, using stoppered, 2 mm pathlength cuvettes and a 
reaction volume of 0.7 ml. A fiavoprotein concentration of 60 yg/ml 
was employed. Flavoprotein-dependent anaerobic reduction of FMN or 
FAP was determined as described in 3.6, using stoppered, 2 mm path­
length cuvettes, a 0.7 ml reaction volume and 60 ]ig purified NADPH- . 
cytochrome £ (P-450) reductase/ml.
5.13. Incorporation of purified NADPH-cytochrome c (P-450) reductase 
into the microsomal membrane.
Purified NADPH-cytochrome £ (P-450) reductase was incorporated 
into the microsomal fraction from control or phenobarbitone-pretreated 
rats by modifications to the method of Gum and Stobel (1979). The 
microsomal fraction, isolated as described in 2.4 was resuspended in 
50 mM sodium phosphate buffer, pH 7.4, containing 0.25 M sucrose
and 0,5 mM EDTA, to a protein concentration of approximately 5 mg/ml.
A sample of this stock suspension (6 ml) was incubated at 37° with 
various amounts of purified fiavoprotein (0 - 200 yg/incubation) in 
a final volume of 8 ml for 20 min, in a shaking water bath (60 cycles/ 
min). After incubation, 17 ml of ice-cold phosphate/sucrose/EDTA 
buffer was added to each flask, and the microsomal fraction sedimented 
at 178,000 g^y for 35 min in the 60 Ti rotor of a Beckman L565 
centrifuge at 4°. The resulting pellet was resuspended in 25 ml of 
ice cold buffer, resedimented as above and resuspended in 6 ml of 
this same phsophate/sucrose/EDTA buffer. Cytochrome P-450 content, 
NADPH-cytochrome c (P-450) reductase activity and azoreductase 
activity were determined as described above.
5.14. Reconstitution of azoreductase activity
Liposomes were prepared by dissolving 3 mg of dilauroylphosphati- 
dylcholine in 0.2 ml chloroform in a 10 ml round bottom flask. The 
solvent was allowed to evaporate. Distilled water (3 ml) was then 
added and sonicated for 10 min at 15° in a Kerry sonic bath, and 
20 yg of the resulting liposome suspension mixed with 1.2 nmol of 
purified cytochrome P-450 and 0.06 nmol of fiavoprotein in a 
stoppered 2 irni pathlength quartz cuvette and incubated at 37° for 
1 min. Non-flavin supplemented azoreductase activity was determined 
at 37° using the above enzyme-1 iposome preparation instead of the 
microsomal fraction. Amaranth and glucose oxidase system concentrations 
were as described in 2.6, in a final volume of 0.7 ml 50 mM sodium 
phosphate buffer, pH 7.4. This mixture m s  warmed for 3 min at 37°, 
after which azoreductase activity m s  initiated by the addition of
0.5 mM NADPH to the sample cuvette. Cofactor was omitted from the 
reference cell. Azoreductase activity was monitored as the decrease 
in absorbance at 520 nm (2.6). Flavin supplemented azoreductase 
activity was determined under similar conditions, after the addition 
of 300 viM FMN to both cuvettes during the 3 min pre-incubation period, 
prior to the introduction of NADPH. The effect of omission of a 
particular component of the reconstituted azoreductase system on the 
rate of amaranth reduction was also studied.
5.15. RESULTS
Trypsin digestion of the microsomal fraction resulted in the 
release of cytochrome £ (P-450) reductase from the microsomal membrane, 
as shown by the large increase in the specific activity of this 
flavoprotein in the 231,600 g^y supernatant (Table 5.1). Cytochrome b,- 
was also solubilised, while NADH-cytochrome b,. (ferricyanide) 
reductase and cytochrome P-450 remained largely bound to the 231,600 g^y 
pellet (Table 5.1). Thus, trypsin treatment provided a crude 
separation of the two components of the NADPH-dependent hepatic 
microsomal electron transport chain.
The non-flavin supplemented azoreductase activity was decreased 
after this treatment and was found to be partitioned between the 
231,600 g^y pellet and supernatant fractions (Table 5.1). The 
activity remaining in the pellet was highly carbon monoxide sensitive, 
while the solubilised azoreductase activity was less influenced by
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this inhibitor. Flavin supplementation of these trypsin treated 
fractions resulted in increased azoreductase activity in the 
supernatant fraction (Table 5.1). The magnitude of this increase 
was comparable to that observed with the untreated microsomal 
fraction. However, flavin supplementation of the 231,600 g^y 
pellet resulted in no increase in activity when compared to the 
non-flavin supplemented activity (Table 5.1).
The decreased non-flavin supplemented azoreductase activity
of the trypsin-digested supernatant resulted from a large increase
in the K for amaranth, with a simultaneous decrease in the maximal m ’
velocity of the reaction (Fig. 5.1). Upon supplementation with 
FMN, the azoreductase activity of this solubilised fraction showed 
biphasic kinetics, as did the untreated microsomal fraction 
(Fig. 5.2). However, trypsin digestion slightly decreased the 
(uM BIN) and Vmax (n mol amaranth reduced/min/mg microsomal 
protein) observed for the "slow phase", while the "fast phase" 
exhibited a pronounced increase in both of these kinetic constants 
(Fig. 5.2).
A more homogeneous preparation of NADPH-cytochrome c (P-450) 
reductase was purified by ion-exchange and affinity chromatography 
on two separate occasions. The purified flavoprotein obtained on 
the first and second occasions will be referred to as Fp-1 and Fp-2 
respectively. Both preparations showed similar behaviour patterns 
on elution from DEAE-cellulose (Fig. 5.3) and 2',5t-ADP Sepharose 4B
Effect of trypsin solubilisation on non-flavin supplemented
azoreductase activity
2.Ch
1.0 -
0.04
K V
m max
Control microsomal fraction (o) 26 3
Trypsin solubilised fraction (©) 40 2
Results represent the mean of triplicate determinations after correction for
non-microsomal reduction mediated-by the NADPH-generating system.
K , s : viM amaranth m*
V , v : nmol amaranth reduced/min/mg protein.
HLclA
Effect of trypsin digestion on flavin supplemented
azoreductase a c t i v i t y
0.30*1
0.08 i0.04
"slow phase" "Fast phase"
K V K Vm max m max
Control micreseed fraction (o) 6 7 157 17
Trypsin solubilised fraction (•) 5 4 541 23
Results represent the mean of triplicate determinations corrected for
non-microsomal reduction mediated by the NADPH-generating system.
K , s : yM BINm* •
V x » v • nrn° l  amaranth reduced/m in/m g p r o te in .
Elution of NADPH-cytochrome c (P-450) reductase activity
from DEAE cellulose under conditions of increasing ionic strength
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604020
Fraction (10 ml)
KC1 gradient
(Fig. 5.4). Fp-1 displayed a 114-fold increase in specific activity 
towards cytochrome £, with a yield of 52% (Table 5.2); Fp-2 showed 
a 170-fold increase in NADPH cytochrome c (P-450) reductase activity, 
with a 431 yield (Table 5.3). Under slightly modified assay 
conditions (0.3 M potassium phosphate buffer, pH 7.7 at 30°, containing 
0.1 mM EDTA) the specific activities increased to 34.3 and 44.1 y mol 
cytochrome c reduced/min/mg flavoprotein, for Fp-1 and Fp-2 respectively. 
These values are in close agreement with the activities reported in 
the literature of 43.8 - 54.6 y mol/min/mg under identical conditions 
(Yasukochi and Masters, 1976).
Polyacrylamide gel electrophoresis in the presence of 0.1%
(w/v) SDS revealed these preparations to be extensively purified in 
comparison to the original microsomal material (Fig. 5.5). Fp-2 ran 
as one major band with an electrophoretic mobility of 0.33 corresponding 
to a molecular weight of 77,600 (Fig. 5.6). Two contaminating bands 
with electrophoretic mobilities of 0.24 and 0.37 corresponding to 
molecular weights of 92,300 and 71,600 were also present. Fp-1 
ran as one major band and one minor band, corresponding to molecular 
weights of 77,600 and 71,600 respectively. NADPH-cytochrome c (P-450) 
reductase purified by this same method has a reported molecular 
weight of 79,000 (Yasukochi and Masters, 1976).
The absolute spectra of Fp-1 and Fp-2 were typical of this 
flavoprotein (Dignam and Strobel, 197 5; Yasukochi and Masters, 1976) 
with peaks at 382 nm and 455 nm and a shoulder at 476 nm (Fig. 5.7).
No contamination by other microsomal proteins was detected.
149
Fig. 5,4.
Elution of NADPH-cytochrome c (P-450) reductase activity 
from 2*,51ADP-Sepharose 4B with 1 mM 2’AMP
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Table 5.2
Purification of rat liver NADPH-cytochrome c (P-450)
reductase (Fp-1) by ion exchange and affinity chromatography
Preparation Total protein^ . activity^
Specific^ 
activity
Yield from 
microsomes
Microsomes
Solubilised
microsomes
2,835
2,495
DE 52 eluant 437
Affinity eluant 13
369
374
350
193
0.13
0.15
0.80
14,86
100
101
95
52
mg protein
ymol cytochrome c reduced/min
ymol cytochrome c r educed/m in/mg protein
©\
0 
©\
0 
Q\
© 
©
\
0
Table 5.3
Purification of rat liver NADPH-cytochrome £ (P-450) 
reductase (Fp-2) by ion exchange and affinity chromatography
•p-i.->1 w ^+^„l Total 0 Specific-, Yield from Preparation Total protein . . . ... 2 1. . •. 3 £------   £-------- activity activity microsomes
Microsomes 2,810 337 0.12 100%
Solubilised
microsomes 2,597 364 0.14 108%
DE 52 eluant 474 332 0.70 99%
Affinity eluant 7 144 20.54 43%
1
mg protein
2
pmol cytochrome c reduced/min
3
pinol cytochrome c r educ ed/m in/mg
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Fig. 5,5 continued
Molecular weight. markers 1 , 2, 10, 18
Albumin (bovine serum) A
Catalase B
Albumin (hen egg) C
Aldolase D
Chymotrypsin E
Purified NADPH-cytochrome c 
(P-450) reductase 
Fp-1 
Fp-2
Eluant from DEAE cellulose 
ion exchange column 
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Hepatic microsomal proteins from 
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Standards for molecular weight estimation.
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°-° 4.3 4.5 4.7
Chymotrypsinogen A 
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The purified flavoprotein was capable of donating electrons 
to FMN and FAD under anaerobic conditions, and a linear relation­
ship was found between flavin concentration and the rate of flavin 
reduction (Fig. 5.8). FMN appeared to undergo reduction at a faster 
rate than equimolar FAD at all flavin concentrations studied.
Plotting this data according to the method of Lineweaver and Burk 
(Plowman, 1972) gave two straight lines that passed through the 
origin, assigning infinite values to Km and Vmax (Fig. 5.9). However, 
the purified flavoprotein was unable to donate electrons directly 
to amaranth, since the rate of azoreduction in the complete assay 
system did not differ significantly from that mediated by the NADPH- 
generating system alone (Table 5.4). Nevertheless, inclusion of both 
amaranth and flavin in this anaerobic system resulted in an appreciable 
rate of azo dye reduction, which varied in direct proportion to changes 
in flavoprotein concentration (Fig. 5.10). At a flavoprotein 
concentration of about 60 yg/ml, the rate of flavin supplemented 
amaranth reduction was dependent upon flavin concentration (Fig. 5.11). 
A Lineweaver-Burk plot of this data gave a linear relationship 
between azoreductase activity and flavin concentration (Fig. 5.12). 
However, in contrast to Fig. 5.9, these experiments assigned 
apparently finite values to and Vmax for this flavin-supplemented 
azoreductase activity.
Incubation of the control microsomal fraction with various 
concentrations of detergent solubilised, purified NADPH-cytochrome c 
(P-450) reductase resulted in an increase in the NADPH-dependent 
reduction of cytochrome £ (Table 5.5). However, both the flavin 
non-supplemented and supplemented activities remained largely unchanged.
1 * '-Fig- 5»8-
Anaerobic reduction of flavin by purified NADPH-cytochrome c
(P-450) reductase (FP-1)
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Results represent the mean of triplicate determinations after correction for 
flavin reduction mediated by the NADPH generating system.
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NADPH-cytochrome c (P-450) reductase (Fp-1)
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Table 5.4
Anaerobic reduction of amaranth by purified NADPH-cytochrome c
(P-450) reductase (Fp-1)
Dye concentration Azoreductase activity
QjM) (nmol amaranth reduced/min/ml)
Complete assay No flavoprotein
system_____
50 1.13
+
0.14 0.86
+
0.06
100 1.89
+
0.11 1.34
+
0.14
150 2.44
+
0.26 2.62
+
0.11
300 4.50
+
0.44 4.50
+
0.37
500 5.64
+
0.26 5.11
+
0.26
Results represent the mean and standard deviation of triplicate 
determinations.
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Fig. 5.10
Variation of flavin supplemented azoreductase activity with 
flavoprotein concentration (Fp-1)
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Results represent the mean of triplicate determinations in the presence of 
300 pH FMN, after correction for reduction mediated by the NADPH- 
generating system.
Influence of supplementary flavin on the azoreductase activity of
purified NADPH-cytochrome c (P-450) reductase (Fp-1)
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Lineweaver-Burk plot of flavin supplemented azoreductase activity 
catalysed by purified NADPH-cytochrome c (P-450) reductase (Fp-1)
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Table 5.5
Binding of NADPH-cytochrome c (P-450) reductase (Fp-2) to the
microsomal fraction from untreated rats
Amount of Cytochrome P-450 Cytochrome c_ reduct­- Azoreductase activity
Fp-2 added'*'
2
content ase activity -FMN4 +FMM
0.00 0.72 117.85 - 3.16 2.46 - 0.16 11.54 - 0.16
0.25 0.71 124.65 - 9.38 2.59 - 0.07 12.32 i 0.35
0.50 0.71 128.70 - 7.57 2.52 - 0.25 11.66 - 0.37
1.00 ' 0.70 137.25 - 4.10 2.28 - 0.18 11.39 - 0.17
* ml of Fp-2 added (stocxc 
2
nmol cytochrome P-450/mg microsomal protein 
nmol cytochrome c reduced/min/mg microsomal protein 
nmol amaranth reduced/min/mg microsomal protein.
Cytochrome P-450 content represents the mean of duplicate determinations. 
Enzyme activities represent the mean and S.D. of triplicate determinations 
Azoreductase activity was determined in the absence (4) or presence (5) 
of 300 jjM FMN and corrected for non-microsomal reduction mediated by the 
NADPH-generating system.
Incorporation of additional flavoprotein into the microsomal fraction 
from phenobarbitone pretreated rats also resulted in increased 
NADPH-cytochrome c CP-450) reductase activity'and also enhanced 
azoreductase activity in both the absence and presence of supplementary 
flavin (Table 5.6).
The phenobarbitone-type cytochrome P-450 purified from the rat 
liver microsomal fraction eluted as two peaks from DEAE-cellulose 
(Fig. 5.13). Those fractions with an A - 417 nm equal to or greater 
than 0.5 possessed a specific cytochrome P-450 content of 15.8 nmol/mg 
protein when pooled,with 5% yield (Table 5,7). Subsequent treatment 
of this material with Amberlite XAD-2 lowered the specific content to 
14.4 nmol cytochrome P-450/mg protein. This represented a 7.5-fold 
increase in specific content in comparison to the starting material.
For comparison, West 'et 'al_. (1979) reported a 14.5% yield, with a 
specific content of 16.1 nmol/mg using a similar procedure.
%
Polyacrylamide gel electrophoresis of this purified Iiaemoprotell1 
revealed the presence of only one band (fig. 5.14) with an electro­
phoretic mobility of 0.51. This corresponded to a molecular weight 
of 51,800 (Fig* 5.15), a result in close agreement with the published 
value of 52,000 (West et al., 1979). The carbon monoxide difference 
spectrum of the dithionite-reduced haemoprotein showed a single peak 
at 450 nm (Fig.- 5.16). Estimations for cytochrome b^ and NADPH- 
cytochrome £ (P-450) reductase contamination were negative. However, 
this apparently homogeneous preparation contained some NADH-cytochrome 
be- (ferricyanide) reductase activity, equivalent to 6.8 ymol ferricyanide 
reduced/min/mg protein. This represented a two-fold increase in the
Table'5.6.
Binding of NADPH-cytochrome c (P-450) reductase (Fp-2) to the 
microsomal fraction from phenobarbitone pretreated rats
Amount of 
Fp-2 added'
0.00
0.25
0.50
1.00
Cytochrome P-450 Cytochrome c reduct- Azoreductase activity 
2 ------------- *---------- 2 e
content
1.85
1.78
1.87
1.94
ase activity*
131.84 i 2.49 
130.09 - 6.83 
150.29 - 8.02 
168.53 - 6.02
-FMir +FMN
4.67 - 0.11 14.37 - 0.7
4.41 - 0.11 14.60 i 0.5
5.15 - 0.13 17.88 - 1.2
5.24 - 0.21 18.52 - 1.0
ml of Fp-2 added Cd/kqaa.W’Kcv'
2
nmol cytochrome P-450/mg microsomal protein
3
nmol cytochrome c reduced/min/mg microsomal protein
4 5* nmol amaranth reduced/min/mg microsomal protein.
Cytochrome P-450 content represents the mean of duplicate determinations. 
Enzyme activities represent the mean and S.D. of triplicate determinations 
Azoreductase activity was determined in the absence (4) or presence (5) 
of 300 yM FMN and corrected for non-microsomal reduction mediated by the 
NADPH-generating system.
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Fig. 5.13
Elution of cytochrome P-450 from DFAE cellulose under 
conditions of increasing ionic strength
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Table 5,7
Purification of cytochrome P-450 by ion exchange chromatography
Preparation Total protein Total Specific Yield from2 3content content microsomes
Micro somes 3,500
Solubilised
microsomes 3,360
PEG C10-16%) 712
DE 52 eluant 21
XAD2 eluant 20
6.69
5.07
2.62
0.33
0.28
1.91
1.51
3.68
15.80
14.41
100%
76%
39%
51
4%
mg protein
pmol cytochrome P-450
nmol cytochrome P-450/mg protein
168
Fig. 5.14
Polyacrylamide gel electrophoresis of microsomal proteins 
and purified, cytochrome P-4 50
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Fig. 5.15.
Standards for molecular weight estimation
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Fig, 5.16.
Carbon monoxide difference spectrum of dithionite reduced 
purified cytochrome P-450
0.01 A
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specific activity.’dfthis flavoprotein, the control microsomal fraction 
possessing an activity of 3.6 y mol/min/mg.
Azoreductase activity was reconstituted into dilauroylphosphatidyl- 
choline liposomes from purified cytochrome P-450 and purified NADPH- 
cytochrome £ (P-450) reductase. In the absence of supplementary FMN, 
amaranth reduction was completely dependent upon these three 
components, with the omission of any one component abolishing this 
activity (Table 5.8). Supplementation with FMN increased the azo­
reductase activity of the complete system about 7-fold. In contrast 
to the non-flavin supplemented assay, the omission of any one component 
failed to abolish amaranth reduction. Thus, liposomes containing either 
purified flavoprotein or purified haemoprotein possessed 30% and 141 
respectively of the flavin supplemented azoreductase activity of the 
complete system, while the omission of phospholipid gave a NADPH- 
cytochrome c (P-450) reductase/cytochrome P-450 dependent activity that 
was about 60% of that present in the complete system.
5.16. DISCUSSION
Disruption of the microsomal fraction by trypsin digestion 
resulted in the release of NADPH-cytochrome c (P-450) reductase from 
the microsomal membrane and into solution, along with smaller amounts 
of other microsomal electron transfer proteins. The net effect of 
this treatment was a decrease in the NADPH-dependent rate of cytochrome 
£ reduction in the 231,600 g^y pellet, with a three-fold increase in 
this activity in the supernatant fraction.
Table 5,8
Reconstitution of azoreductase activity by purified NADPH-cytochrome 
£ CP-450) reductase (Fp-2), purified cytochrome P-450 
and d ilauroylpho sphat idylcho1ine
Conditions Non-flavin supplemented Flavin supplemented
azoreductase activity reductase activity
(nmol amaranth r educ ed/m in/ml)
Complete syston 
Minus Fp-2^ 
Minus P-4503 
Minus lipid^
1,19 - 0.12 
0.00 
0.00 
0.00
7.99 - 0.56 
1.08 - 0.14 
2.40 - 0.19 
4.69 - 0.76
Liposomes containing NADPH-cytochrome c (P-450) reductase and 
cytochrome P-450.
Liposomes containing cytochrome P-450.
Liposomes containing NADPH-cytochrome c (P-450) reductase. 
NADPH-cytochrome c (P-450) reductase and cytochrome P-450 in the 
absence of lipid.
azo-
Results represent the mean and S.D. of triplicate determinations. 
Azoreductase activity, corrected for non-enzymic reduction mediated by 
the NADPH-generating system, was determined in the absence or presence
The partial removal of this flavoprotein from the microsomal 
membrane decreased the activity of the non-flavin supplemented 
azoreductase activity present in the 231,600 g^y pellet. This 
residual activity was highly sensitive to carbon monoxide inhibition, 
but failed to show any stimulation of activity upon supplementation 
with FMN. This indicates that the decreased activity of this 
flavoprotein in the particulate fraction decreased the rate of 
electron transfer to cytochrome P-450 and thereby limited this 
azoreductase activity even in the presence of soluble flavin. In 
addition, this proteolytic treatment may have also resulted in some 
inactivation of cytochrome P-450.
Tr^sin digestfon solubilised about 50$ of the non-flayin 
supplemented azoreductase activity present in the untreated microsomal 
fraction. This activity was again sensitive to carbon monoxide 
inhibition in spite of the fact that only a small amount of 
cytochrome P-450 was spectrally detectable in the supernatant 
fraction. Flavin supplementation of this solubilised material resulted 
in a 7-fold increase in azoreductase activity. This increased activity 
was comparable in magnitude to that observed upon supplementation of 
the untreated microsomal fraction. However, neither the non-flavin 
supplemented nor the flavin supplemented azoreductase activities 
paralleled the large increase in NADPH-cytochrome £ (P-450) 
reductase activity observed in the soluble phase after trypsin 
solubilisation of the microsomal fraction. This suggests little
direct interaction between this flavoprotein and flavin and/or 
amaranth.
Purification of NADPH-cytochrome c (P-450) reductase to near 
homogeneity resulted in a massive increase in the specific activity 
of this flavoprotein when cytochrome c was used as electron acceptor. 
However, this purified flavoprotein was incapable of directly reducing 
amaranth and required supplementary flavin in order to express azo­
reductase activity. The kinetics of the interaction between NADPH- 
cytochrome c (P-450) reductase and flavin approximated a first order 
chanical reaction, with the velocity of flavin reduction varying in 
proportion to the concentration of FMN or FAD. A Lineweaver^Burk
plot of this data assigned infinite values to Jf and for thejij jijax
activity, indicating the absence of a classical enzyme-substrate 
complex, Under these conditions, enzyme activity'will be diffusion 
rate-limited and dependent upon random collisions between the reduced
it
flavoprotein and flavin. In contrast, the kinetics for the flavin 
supplemented azoreductase activity'of purified NApPH^ytochronjevc^ 
(P-450) reductase gave apparently'finite values to and V .
However, the magnitude of these constants suggests, that they do not 
differ greatly from the non-enzymic model proposed for the reduction
i
of flavins by purified NADPH-cytochrome £ (P-450) reductase, Moreover, 
the initial step during this flavin-mediated reduction of amaranth1, 
the reduction of FAD or FMN by' the flavoprotein, should display' 
kinetics similar to those aiready discussed, Thus1, the rate of 
amaranth reduction will be totally'dependent upon coll is ions between 
reduced flavin and amaranth, since NADPH-cytochrome'£. CPr450 
reductase does not reduce amaranth directly. Under these conditions, 
this reaction will be dependent upon Cb] the concentration of
I !<
oxidised flavin available to interact with the flavoprotein, and
tii) the concentration of reduced flavin available to reduce amaranth. 
These considerations may affect the overall rate of azo dye reduction.
Incorporation of the purified flavoprotein into the microsomal 
fraction from untreated rats increased the specific activity of the 
bound NADPH-cytochrome c (P-450) reductase, but had no effect on 
either the non-flavin supplemented or the flavin supplemented azo­
reductase activities. In contrast, incorporation of purified NADPH- 
cytochrome £ (Pt450) reductase into the microsomal fraction from 
phenobarbitone treated rats increased the specific activity of both 
the non-flavin supplemented- and the flavin supplemented azoreductase. 
This suggests that in the control microsomal fraction, the amount of 
flavoprotein present was able to effect the efficient transfer of 
electrons from NADPH to cytochrome P-450. However, the increased 
microsomal cytochrome P-450 content present after phenobarbital 
induction resulted in haemoprotein reduction becoming rate limiting. , 
The incorporation of additional NADPH-cytochrome c (P-450) reductase 
in this microsomal fraction increased the rate of cytochrome P-450 
reduction and increased azoreductase activity. These observations 
explain the lack of correlation between flavin supplemented azo­
reductase activity and the increases in cytochrome P-450/P-448 
reported in 4.13.
Reconstitution studies utilising purified NADPH-cytochrome c 
(P-450) reductase, purified cytochrome P-450 and dilaurylphosphatidyl- 
choline liposomes demonstrated an absolute dependence of the non-
flavin supplemented azoreductase activity upon all three of these 
components. The omission of any one component abolished azoreductase 
activity. This is in contrast to the flavin supplemented activity, 
where any two of the above components could partially reconstitute 
amaranth reduction. However, all three factors were required for 
maximal activity. Further, the purification of these microsomal 
enzymes and the reconstitution of azoreductase activity resulted in 
an increased activity over that present in the microsomal fraction.
In the reconstituted system, activities of 6 nmol amaranth reduced/ 
min/nmol cytochrome P-450 and 40 nmol amaranth reduced/min/nmol cyto­
chrome P-450 were recorded in the absence and presence of supplementary 
flavin respectively-. In contrast, activities of about 5 nmol 
amaranth reduced/min/nmol cytochrome P-450 and about 20 nmol amaranth 
reduced/min/nmol cytochrome P-450 are usual for the non-flavin 
supplemented and flavin supplemented microsomal azoreductase activities.
The data reported in this chapter are consistent with previous 
observations which suggested that the hepatic microsomal azo­
reductase is dependent upon cytochrome P-450 for activity (3.10;
4.14). Purification of NADPH-cytochrome c (P-450) reductase 
indicated that this flavoprotein did not interact directly with 
amaranth, but required soluble flavin and/or cytochrome P-450 for 
the efficient transfer of electrons to this azo compound. Further, 
a lipid environment was essential for maximal activity when 
cytochrome P-450 and NADPH-cytochrome c (P-450) reductase were 
combined to reconstitute azoreductase activity.
Chapter 6
DISCUSSION
DISCUSSION
The continuous spectrophotometric assay procedure for hepatic 
microsomal azoreductase activity developed in these studies 
permitted a more accurate and detailed investigation into the 
kinetics and mechanism of this reaction than was possible with 
the fixed time assays used by other workers (Mueller and Miller, 
1948; Hernandez et al., 1967a; Autrup and Warwick, 1975).
Caution must therefore be exercised before making comparisons 
between the results obtained with this system and earlier 
studies, in which variable lag periods were likely before the 
initiation of reduction. In addition, lipid soluble or water 
soluble azo compounds may undergo reduction by different mechanisms 
reflecting their solubility in the microsomal membrane (Albrecht 
et al., 1972); this may further complicate the interpretation
of data from different research groups. The studies reported 
in this thesis relate to the reductive metabolism of the polar 
aromatic mono azo dye amaranth.
Microsomal azoreductase activity was greatest when NADPH
was cofactor, with NADH a less efficient electron donor. The
/
addition of soluble flavins to the system increased the NADPH- 
deperident activity by four to five fold, with little effect on 
NADH-supported amaranth reduction. This increase in activity 
appears to result from riboflavin, FMN or FAD participating as 
soluble electron transporting agents from some NADPH-dependent 
microsomal enzyme to the azo acceptor compound.
The effects of carbon monoxide, type I substrates and 
type II ligands were consistent with cytochrome P-450 as the 
teiminal electron donor to flavins and/or amaranth, and azo- 
reduction paralleled the decreased microsomal cytochrome P-450 
content recorded after pretreatment of rats with cobaltous 
chloride or allylisopropylacetamide. A similar relationship 
between cytochrome P-450 content and amaranth reduction was 
described by Fujita and Peisach (1978a).
Cytochrome P-450 has also been implicated as the terminal 
electron donor involved in the anaerobic reduction of tertiary 
amine N-oxides (Sugiura et al., 1974; Iwasaki et al., 1977), 
nitro compounds (Gillette et al_., 1968; Sasame and Gillette, 1969) 
and the anaerobic, reductive dechlorination of trichlorofluoro- 
methane (W°lf et al., 1978). The proposed site of interaction 
between cytochrome P-450 and these various substrates was the 
type IIiron -centre of this haemoprotein. Similar conclusions 
were drawn in these present studies for the interaction between 
cytochrome P-450 and flavins, but amaranth reduction appeared 
to be at a location distinct from either the type I or type II 
binding sites. The exact nature of this reaction between 
cytochrome P-450 and amaranth requires further investigation.
The partial or complete purification of the flavoprotein 
NADPH-cytochrome c (P-450) reductase by trypsin or detergent 
treatment indicated that this flavoprotein was unable to reduce
amaranth directly. These observations contrast with the findings 
of Hernandez et al. (1967a, b) who reported that a semi-purified 
preparation of this flavoprotein was capable of reducing neo- 
prontosil, These authors also proposed that the residual azo­
reductase activity present after exposure of the microsomal 
fraction to carbon monoxide was further evidence for a 
direct flavoprotein - azo dye interaction (Hernandez et al., 1967a, b). 
However, thisnCO-insensitive” activity may reflect incomplete 
inhibition of cytochrome P-450, a factor consistent with the carbon 
monoxide dependent, non-competitive inhibition of amaranth reduction 
recorded in these present studies. Nevertheless, NADPH-cytochrome c 
(P-450) reductase is required for the transfer of electrons from 
NADPH to cytochrome P-450, and treatments which impaired this 
function (trypsin, 2-bromo-4'-nitroacetophenone) also decreased the 
rate of flavin and/or azo dye reduction by the microsomal fraction. 
Electron transport to this haemoprotein was also rate limiting 
during the flavin supplemented reduction of amaranth catalysed 
by the microsomal fraction from phenobarbitone treated rats, a 
factor that was corrected by the incorporation of additional 
purified NADPH-cytochrome c (P-450) reductase into the microsomal 
membrane.
While the majority of these observations were consistent with 
a haemoprotein azoreductase, flavin supplemented azoreductase activity 
was apparently independent of cytochrome P-450 content following 
carbon tetrachloride damage to the microsomal fraction. This may 
reflect the uncoupling of electron transport from NADPH to
cytochrome P-450, allowing NADPH-cytochrome c (P-450) reductase ■ 
to function as an azoreductase via soluble flavins. Such a 
suggestion complements the observation that this purified flavo­
protein was capable of reducing flavins, and possessed azo­
reductase activity in the presence of FMN and FAD.
The biphasic kinetic plots obtained for the flavin supplemented 
microsomal azoreductase activity indicated a complex interaction 
between cytochrome P-450 and amaranth and/or FMN. In the absence 
of flavin, and at low levels of flavin supplementation, amaranth 
reduction was postulated to be due to a direct interaction between 
the azo dye and cytochrome P-450. However, at high levels of 
flavin supplementation (100 yM FMN and above), electron transport 
from cytochrome P-450 to amaranth appeared to change to a 
mechanism mediated via a soluble flavin shuttle. At intermediate 
flavin concentrations both mechanisms were postulated to be 
operative, with the predominance of a particular pathway depending 
on the affinity of cytochrome P-450 for the flavin or azo dye, 
and the relative concentration of each substrate.
These kinetic studies suggest that high concentrations of 
flavin are required for the efficient reduction of azo compounds. 
Hepatic tissue is reported to contain about 25 yM total flavin 
(Long, 1961) which may be too low for this mechanism to operate 
effectively. Under these conditions, any hepatic azoreductase 
activity in vivo would occur via the direct transfer of electrons
from cytochrome P-450 to the azo acceptor. However, rats 
maintained on a diet containing additional riboflavin showed 
increased azoreductase activity when the post-mitochondrial 
supernatant fraction was incubated with butter yellow in vitro 
(Williams et al., 1970) suggesting a greater involvement of 
the flavin, dependent pathway.
Flavin supplementation also increases other anaerobic, 
reductive activities catalysed by the hepatic microsomal fraction 
such as the dechlorination of trichiorofluoromethane (Wolf et al., 
1978), nitro reduction (Fouts and Brodie, 1957; Gillette, 1971) 
and tertiary amine N-oxide reduction (Iwasaki et ajL, 1977). The 
mechanisms involved in the former examples have received little 
attention. However, the stimulation of tiaramide N-oxide 
reduction by riboflavin, FMN or FAD was consistent with flavins 
increasing the rate of electron transfer from NADPH-cytochrome c 
(P-450) reductase to cytochrome P-450 (Iwasaki et al_., 1977).
The reason for this fundamental difference between the flavin 
enhanced reduction of N~oxides and azo compounds is unknown, but 
may reflect differences in the rate limiting step involved in 
the cytochrome P-450 dependent reduction of tiaramide N-oxide and 
amaranth.
£n conclusion, the observations presented in this thesis are 
consistent with the following models for the microsomal reduction 
of amaranth and flavins:
l b ' 6
(i) NADPH ► NADPH-cytochrome c ----► Cytochrome ---- ► Amaranth
(P-450) reductase P-450
(ii) NADPH ►NADPH-cytochrome c  ►Cytochrome  ►Flavins — ►Amaranth
(P-450) reductase P-450
Thus, the determination of microsomal azoreductase activity with 
amaranth as substrate provides a method for the rapid estimation 
of NADPH-dependent reduction of cytochrome P-450, and the integrity 
of electron transport from NADPH-cytochrome c (P-450) reductase to 
this haemoprotein.
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